rfhg_3842.1

Basic information about the TSS

---

TSS ID: rfhg_3842.1 TSS ID(Version3): hg_1644.1 hg_1645.1 Species: human Chr: chr1		Start: 26695995 End: 26696098 Strand: +
Source datasets	FANTOM5|PRJNA548673|PRJNA401781|PRJNA615891|PRJNA4843412 |DRA013844
Protocol	CAGE|SLIC_CAGE|RAMPAGE|NETCAGE
TSS cluster detected*	7

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2142212,EH38E1330710)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000324856.13:0 ENST00000637465.1:0 AF231056:0 GeneID: 8289 HGNC/MGI_ID: HGNC:11110 UniProt_ID: A0A1B0GVT5 O14497 Nearer transcript ids and distances: ENST00000457599.6:306

Gene_name: AT-rich interaction domain 1A Gene_symbol: ARID1A Gene_synonyms: B120 BAF250 BAF250a C10rf4 P270 Gene_source: HGNC:11110

TATA-Box annotation

---

Distance to TSS:	31
Nearest PromoterID:	NM_006015
Entrez ID:	8289
Nearest Unigene:	Hs.468972
Nearest Refseq:	NM_006015
Nearest Ensembl:	ENSG00000117713
Gene Name:	AT-rich interaction domain 1A
Gene Alias:	B120|BAF250|BAF250a|BM029|C1orf4|CSS2|ELD|MRD14|OSA1|P270|SMARCF1|hELD|hOSA1
Gene Type:	protein-coding
CpG%:	0.048544
GC%:	0.711538
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARID1A p2@ARID1A p3@ARID1A p4@ARID1A p5@ARID1A p6@ARID1A p7@ARID1A p10@ARID1A
Sample		p1@ARID1A	p2@ARID1A	p3@ARID1A	p4@ARID1A	p5@ARID1A	p6@ARID1A	p7@ARID1A	p10@ARID1A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.13	20.65	3.70	0.97	0.39	2.92	0.78	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.94	17.40	4.25	2.23	1.21	3.84	0.81	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.42	21.41	5.40	1.35	0.58	2.70	0.58	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.24	14.76	2.08	1.46	0.42	3.53	1.04	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.65	25.65	3.60	1.35	1.12	2.47	0.22	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.59	16.86	2.33	1.55	0.19	1.74	0.78	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.02	16.12	4.36	5.88	0.44	3.49	2.18	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.20	13.81	4.12	3.88	0.97	1.94	0.97	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	11.54	14.32	3.85	7.05	0.43	3.85	1.07	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	11.01	3.48	23.19	0.00	1.16	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.87	14.55	4.85	16.57	1.21	4.04	2.02	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.54	14.23	1.63	27.65	0.00	2.03	1.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	10.32	15.96	2.58	0.00	0.81	1.77	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.86	10.22	2.41	0.15	0.00	1.50	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.56	8.12	2.42	0.00	0.44	0.66	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.54	8.05	2.01	0.00	1.01	0.75	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.90	7.64	1.53	0.00	0.22	1.97	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.59	7.59	3.80	0.42	0.42	2.95	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.86	11.73	0.00	0.53	0.00	2.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.18	11.58	2.41	0.00	0.45	0.90	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	7.89	11.49	3.74	0.00	0.00	1.34	0.40	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.60	12.77	2.42	0.35	0.35	1.38	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.63	8.79	1.94	0.39	0.39	1.03	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.07	12.13	2.43	0.49	0.73	1.94	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.03	13.16	2.58	0.77	0.26	1.81	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.55	11.71	0.95	0.32	0.95	2.22	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.40	14.84	1.10	0.00	0.00	2.20	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.67	12.49	1.41	0.00	1.41	1.41	0.24	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.37	10.50	2.91	0.81	0.32	0.48	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.78	11.04	2.35	0.36	0.72	1.27	0.90	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.91	8.16	2.72	0.42	0.84	2.30	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.42	10.16	2.54	0.59	1.37	0.98	0.39	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	5.91	11.61	2.74	0.63	0.21	1.06	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	5.28	8.25	2.80	0.99	0.33	1.98	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.73	10.66	1.87	0.75	0.56	0.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	7.66	9.77	1.15	0.00	0.77	1.15	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.13	9.81	1.43	0.41	0.41	1.64	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.64	11.28	3.22	0.20	0.20	0.60	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.48	9.99	1.08	1.62	0.54	1.62	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.44	7.68	2.64	0.48	0.00	0.96	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.65	5.88	2.82	0.24	1.65	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.12	10.10	1.76	0.44	0.29	0.88	0.73	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.33	6.33	1.69	0.63	0.84	0.63	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	4.55	7.69	2.45	0.52	0.35	1.22	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	7.43	8.43	1.20	0.80	0.40	0.40	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.44	6.05	3.95	0.70	0.70	0.00	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.32	9.60	1.44	0.48	0.48	1.20	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.05	7.45	0.89	0.89	0.60	0.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	7.42	3.35	1.44	0.72	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.09	10.92	3.03	0.20	0.81	0.61	0.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.27	6.97	2.46	0.41	0.61	1.02	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.67	10.45	2.45	1.56	0.22	1.11	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	4.61	1.42	1.06	0.71	1.06	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.29	5.30	0.33	0.66	0.66	1.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	14.26	4.19	0.84	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	6.89	0.46	0.00	0.46	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.08	5.51	2.27	0.65	0.32	0.65	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.03	4.50	1.61	0.32	0.32	0.32	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.49	9.74	3.14	0.31	0.31	0.94	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	7.05	0.71	0.00	0.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	4.49	1.68	0.56	0.00	0.00	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.18	17.52	3.18	0.00	0.80	0.00	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.51	10.19	3.06	0.68	0.68	0.68	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.37	6.82	2.60	2.27	1.30	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.00	5.68	0.00	0.35	1.42	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	31.59	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.68	2.93	0.49	0.00	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.95	3.47	0.99	0.00	0.50	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	6.10	0.47	0.47	0.47	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.63	8.94	0.66	0.00	0.33	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.35	6.19	0.62	0.00	0.62	0.00	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	4.59	0.00	0.00	0.92	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	3.33	2.53	0.95	0.00	0.48	0.48	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	3.69	4.17	2.25	0.16	0.80	0.16	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	3.82	4.07	2.42	0.13	0.25	1.02	0.13	0.38
Adipocyte - omental, donor2	11474-119C7	4.48	0.75	1.49	0.00	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	4.69	3.35	1.34	0.00	0.67	0.67	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	3.83	2.55	0.64	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	1.10	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	0.90	0.90	0.45	0.00	0.90	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	4.00	4.52	1.04	0.00	1.04	1.39	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	14.28	9.58	2.35	0.20	1.56	1.37	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	11.58	9.27	1.29	0.00	0.00	0.26	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	11.99	8.08	0.00	0.28	0.00	0.84	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	5.29	9.99	1.76	0.59	1.18	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	12.55	5.23	1.69	0.32	0.72	1.05	0.08	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	9.68	7.75	0.97	0.65	2.26	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	4.27	0.53	0.53	0.00	1.07	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	7.23	3.34	1.11	0.56	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	2.91	1.66	0.00	1.25	0.83	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	5.27	3.77	0.75	0.50	0.50	0.50	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	3.93	0.00	0.00	0.33	1.31	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	5.18	2.44	0.30	0.00	0.30	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	15.03	4.42	1.55	0.44	0.66	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	10.40	4.30	1.08	1.08	0.72	0.36	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	1.20	1.20	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	16.19	7.38	3.60	0.36	0.18	0.36	0.90	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	6.69	3.35	0.00	3.35	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	16.64	5.96	2.88	0.00	0.62	0.41	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	5.49	3.43	1.14	0.00	0.00	0.46	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	6.61	2.69	1.22	0.00	0.73	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.04	0.45	1.35	0.00	0.45	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	1.30	1.74	0.00	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	2.14	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.69	1.79	1.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1.26	2.53	2.53	0.00	0.00	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	2.64	0.00	0.00	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.57	2.27	0.65	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1.46	1.46	1.46	0.00	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1.78	0.00	0.00	0.00	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.03	1.88	0.00	0.00	0.75	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	1.45	0.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	0.00	2.51	1.25	0.00	1.25	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	3.79	0.99	0.66	0.00	0.00	0.00	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1.36	2.73	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.32	1.96	0.45	0.15	0.90	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1.07	1.07	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.97	2.27	0.76	0.57	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	3.47	2.14	0.53	0.00	0.27	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	2.93	1.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1.99	1.66	1.49	0.00	0.50	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1.20	2.40	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.26	1.54	0.69	0.00	0.69	0.17	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	0.97	2.91	0.49	0.00	0.00	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	3.04	1.14	1.52	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1.71	2.28	1.14	0.00	0.57	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	3.85	0.86	0.43	0.00	0.21	0.21	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	2.84	2.32	0.00	0.00	0.26	0.52	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	0.00	1.88	0.00	0.00	0.47	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.86	2.89	0.64	0.00	0.64	0.32	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.28	1.43	0.71	0.00	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	0.00	1.75	0.58	0.58	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	2.41	0.60	1.51	0.00	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	4.75	2.38	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1.53	1.02	1.02	0.00	0.00	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	2.29	1.27	2.29	0.25	0.25	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.45	3.02	0.00	0.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1.48	1.27	0.64	0.00	0.00	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1.74	2.03	0.87	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	0.94	1.89	0.94	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.54	2.20	0.51	0.00	0.34	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	2.11	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1.93	2.36	0.43	0.43	0.64	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1.20	3.01	0.60	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1.46	0.73	1.46	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	3.68	1.38	0.46	0.23	0.00	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	7.65	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1.27	1.27	0.76	0.25	0.51	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.30	2.27	1.03	0.21	0.41	0.62	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.06	1.22	0.61	0.31	0.31	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	2.39	0.96	1.91	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	3.77	2.22	1.33	0.22	0.44	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	4.58	3.05	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	1.11	0.00	0.00	0.55	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	2.65	1.32	0.53	0.26	0.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	0.73	1.45	1.45	0.00	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.47	9.09	2.58	0.74	1.72	0.00	0.74	0.12
Astrocyte - cerebellum, donor2	11580-120F5	13.35	5.31	2.05	0.86	2.23	0.34	0.51	0.51
Astrocyte - cerebellum, donor3	11661-122F5	10.49	9.02	1.05	0.00	0.84	0.42	0.42	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	16.03	7.67	2.79	0.35	1.05	0.70	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	17.80	9.06	2.91	0.16	2.59	0.65	1.94	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	20.58	8.35	2.83	1.04	1.64	0.75	1.19	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	24.54	11.93	5.50	11.24	0.69	1.83	1.03	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.93	10.77	5.14	11.40	0.63	1.25	1.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.56	11.72	5.35	9.90	0.57	1.02	1.37	0.57
Basophils, donor1	12241-129G9	24.58	9.15	2.88	1.83	1.57	0.52	0.00	0.00
Basophils, donor2	12242-129H1	31.75	14.79	3.25	4.69	1.44	1.08	0.72	0.36
Basophils, donor3	12243-129H2	32.19	8.23	3.09	3.38	1.62	1.18	0.29	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	8.41	4.10	1.08	0.22	0.43	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	12.80	5.94	1.37	0.00	0.00	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	3.77	1.88	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.32	3.95	0.42	0.00	0.83	1.04	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.53	2.07	0.46	0.00	0.69	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	9.18	3.24	0.36	0.00	0.54	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	19.17	16.49	2.99	3.71	0.31	0.82	0.21	1.85
Burkitt's lymphoma cell line:RAJI	10476-106I8	33.31	23.99	3.49	11.88	0.93	0.70	1.63	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.90	28.46	2.56	1.92	0.64	2.88	1.28	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	10.34	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	37.19	11.27	2.82	4.51	0.56	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	34.34	8.91	3.90	1.30	1.30	1.11	0.37	0.74
CD14+ Monocytes, donor3	11381-118B4	35.56	12.51	3.07	1.98	0.44	0.22	0.88	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.04	9.34	3.11	0.28	0.85	1.70	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.20	8.72	2.65	0.00	1.14	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.03	12.49	3.62	0.00	1.64	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	20.09	5.64	2.46	0.14	0.29	0.14	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	16.60	4.22	0.91	0.60	0.30	0.91	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	24.16	8.53	2.37	0.24	1.18	0.00	2.13	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.22	2.51	1.51	0.84	0.17	0.00	1.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.11	2.21	0.83	0.55	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.17	4.46	0.25	0.00	0.50	0.25	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.87	2.35	0.98	0.39	0.20	0.20	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	6.77	1.42	0.71	0.18	0.36	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.88	3.48	0.22	0.22	0.00	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.37	3.28	0.94	0.00	0.23	0.23	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.67	8.45	1.06	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	3.33	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.35	4.02	1.34	1.04	0.59	0.30	1.19	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.58	2.00	0.40	0.20	0.60	0.40	0.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.37	3.12	0.62	0.21	0.42	0.21	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	1.37	0.00	0.23	0.23	0.23	1.14	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.30	2.26	0.00	0.23	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.11	2.62	0.00	0.44	0.44	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.53	3.77	1.61	0.00	0.54	0.00	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.12	3.31	0.52	0.00	0.52	0.35	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	20.20	5.05	0.42	0.00	0.84	0.00	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.06	2.02	0.55	0.00	0.00	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	1.41	1.41	0.35	0.00	0.00	1.06	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.46	4.39	0.00	0.88	1.75	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.67	3.84	1.22	0.00	0.70	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	4.46	1.86	0.37	0.74	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.92	6.04	1.51	0.22	0.86	0.43	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.47	3.69	0.82	1.23	0.00	0.82	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.10	2.55	0.93	0.46	0.46	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.80	3.02	0.93	0.70	0.00	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	14.17	10.03	0.22	0.22	0.22	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	18.94	6.24	1.62	0.00	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	13.00	6.07	1.08	0.22	0.87	0.87	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	27.72	14.33	2.34	0.16	0.62	0.93	0.47	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	23.75	12.40	1.75	0.17	0.87	0.70	0.35	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	56.86	16.50	2.01	0.22	0.89	1.11	0.45	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	13.01	10.21	1.79	0.77	0.51	0.77	0.77	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	14.93	5.93	1.32	0.00	0.44	1.10	0.88	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	16.21	8.21	1.89	0.42	0.42	1.05	0.42	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	16.26	0.00	8.13	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	31.86	19.66	1.36	5.42	0.00	1.36	0.68	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	33.14	24.85	7.25	9.32	0.00	0.00	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	35.71	18.12	4.26	5.86	0.00	0.53	0.00	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	30.02	24.66	5.90	6.43	0.54	0.54	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.76	19.65	3.51	4.21	0.00	2.81	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.82	23.53	3.14	3.92	0.00	4.71	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	38.23	19.77	3.95	2.64	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	80.55	23.01	7.40	18.90	0.00	5.75	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	60.94	13.78	6.53	16.68	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	58.05	16.15	4.54	21.20	0.50	1.51	1.01	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	28.69	19.39	4.44	0.81	1.21	2.83	1.21	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.38	15.98	2.00	0.80	0.80	0.80	1.60	1.20
CD34+ Progenitors, donor1	11545-120B6	18.07	6.02	4.02	2.01	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.24	16.29	2.81	7.87	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	22.17	20.67	3.01	0.00	1.50	1.13	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	19.84	25.71	1.13	0.45	2.71	1.13	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	84.62	16.07	11.07	3.21	1.07	0.36	1.43	0.36
CD4+ T Cells, donor2	11306-117C1	61.85	22.05	6.74	6.12	0.00	0.61	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	53.98	15.25	4.88	3.66	1.22	0.61	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	32.16	12.76	2.30	0.51	0.00	0.77	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	37.73	16.17	3.37	0.45	0.45	1.35	0.90	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	35.93	17.54	2.30	0.86	0.00	1.15	1.15	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.55	9.01	5.22	0.95	0.00	0.95	1.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	33.01	16.15	6.32	1.40	0.00	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	16.48	9.89	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.75	8.82	1.73	0.72	0.00	1.16	1.45	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	26.10	17.29	2.54	0.51	0.17	1.19	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	27.57	11.12	2.26	0.97	0.97	0.81	1.29	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	16.14	9.41	2.24	1.34	0.45	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	22.01	9.43	3.84	1.05	0.00	0.35	1.40	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.92	9.24	3.52	1.32	0.00	1.32	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	37.10	18.55	2.11	1.26	0.84	0.84	1.26	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.13	13.92	3.32	1.45	0.62	1.25	1.04	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.72	17.37	4.01	1.34	1.00	0.67	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	43.51	18.49	4.62	2.72	0.00	1.36	1.09	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	46.09	27.87	8.04	2.68	2.14	3.22	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	21.52	7.17	1.79	0.00	7.17	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	34.12	22.62	3.15	1.30	0.19	0.56	0.37	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	29.03	16.25	2.38	0.43	0.22	1.30	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	38.46	18.49	1.68	0.84	0.00	2.10	1.26	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.76	13.15	3.54	1.01	0.00	1.01	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	24.70	12.56	0.43	0.87	0.00	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	36.61	17.87	4.79	3.05	0.00	0.44	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.17	30.68	7.42	1.98	0.49	0.49	0.49	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	37.85	16.62	5.54	0.00	1.85	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	26.52	15.35	4.19	0.00	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	44.86	23.26	5.26	2.22	0.55	2.77	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	53.00	21.59	5.15	5.15	0.98	2.45	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	24.64	4.62	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	40.83	23.64	5.37	1.07	0.72	1.43	1.79	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	33.24	2.77	4.15	0.00	2.77	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	52.71	9.82	7.20	8.18	0.65	0.33	1.96	0.98
CD8+ T Cells, donor2	11307-117C2	56.31	15.77	7.13	4.88	1.13	0.75	2.25	1.13
CD8+ T Cells, donor3	11383-118B6	76.00	25.00	6.56	7.07	0.76	0.76	1.51	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.88	5.96	2.52	11.01	0.00	0.46	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.67	5.75	1.92	13.90	0.48	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.48	5.47	1.09	11.49	0.00	0.27	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.10	6.00	2.10	8.71	0.00	0.00	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.68	7.92	2.88	13.44	0.96	0.24	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.96	7.05	1.59	12.73	0.68	0.45	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.91	5.87	2.61	10.43	0.87	0.65	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.21	6.32	0.53	11.05	0.79	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.49	8.91	2.11	10.32	0.47	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.85	11.47	3.92	13.28	0.30	0.00	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.88	9.30	2.61	8.13	0.58	0.29	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.79	7.46	2.13	9.33	0.27	0.27	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	4.38	1.75	17.95	1.31	0.44	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.32	7.74	4.55	17.76	0.91	0.91	0.46	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	6.71	2.24	27.60	0.00	0.00	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.36	6.12	1.44	10.80	0.36	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.34	6.62	2.01	12.95	0.58	0.58	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.66	5.19	0.94	10.13	0.47	0.47	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.63	6.34	2.85	13.31	0.00	0.32	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.92	5.54	1.85	15.07	0.92	0.31	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.30	7.05	1.60	13.79	0.64	0.64	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	10.71	6.12	1.91	12.24	0.00	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	10.64	4.73	1.58	13.79	0.79	0.00	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	13.62	10.59	5.29	15.13	0.00	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.10	11.24	2.41	54.60	1.61	0.80	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	5.60	4.90	40.57	1.40	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	31.05	9.02	9.02	73.13	2.00	2.00	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	29.24	25.59	3.66	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	7.41	4.45	0.00	0.00	0.00	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	4.63	2.32	0.42	0.00	0.53	0.11	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	6.24	3.81	0.35	0.35	1.04	1.04	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.40	3.55	1.42	0.00	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	2.62	3.07	2.62	0.00	0.11	0.23	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	7.16	0.90	0.90	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	6.87	1.62	2.02	0.00	0.81	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	16.41	7.46	2.30	0.92	1.72	0.69	0.34	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	12.40	8.55	0.86	0.21	1.28	0.64	0.64	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	14.34	8.76	2.04	0.27	2.04	0.71	0.62	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	21.18	11.46	6.42	0.83	0.92	0.92	1.28	0.28
Corneal Epithelial Cells, donor1	11526-119I5	13.17	4.83	0.88	0.00	0.22	0.88	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	17.06	4.55	0.00	0.00	2.28	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	12.01	2.81	1.02	0.26	0.26	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.04	5.28	0.83	0.33	0.17	1.16	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.04	7.57	0.32	0.32	0.32	0.63	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	13.80	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.64	4.21	0.86	0.11	0.11	1.19	0.43	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	26.65	12.64	5.12	6.15	0.68	1.02	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.71	14.36	5.22	5.22	0.65	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.00	14.03	6.78	3.39	1.45	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	9.67	6.17	0.17	0.50	1.33	0.83	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	2.93	0.00	0.00	1.17	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.96	7.64	1.70	0.00	0.28	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.83	5.90	0.79	0.39	0.00	0.00	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.94	3.49	1.16	0.58	0.00	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.71	6.12	1.41	0.24	0.71	0.71	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	8.77	3.33	1.05	0.35	0.88	0.35	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.97	5.10	1.55	0.00	0.44	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.91	5.48	0.61	0.30	0.61	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.43	4.23	0.56	0.56	0.28	0.00	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	4.75	2.67	1.49	0.59	0.30	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	9.89	4.17	1.04	0.00	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.96	4.54	2.98	0.14	0.57	0.57	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	7.20	4.00	0.40	0.40	0.40	1.20	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	3.67	4.19	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.52	9.32	2.11	0.62	1.12	0.75	0.99	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.16	10.65	1.52	0.22	0.65	0.87	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	19.54	8.43	0.85	0.85	1.34	0.98	1.10	0.49
Endothelial Cells - Vein, donor1	11267-116G7	14.79	9.10	2.28	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	3.49	0.70	0.00	0.70	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.30	4.55	0.47	0.00	1.10	0.63	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	62.71	6.60	31.35	14.85	4.95	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	42.80	7.13	10.70	3.57	7.13	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.68	2.93	0.49	0.00	0.73	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.28	4.52	0.00	0.00	0.82	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.75	0.99	0.88	0.00	0.44	0.22	0.00	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.71	4.23	0.87	0.11	0.76	0.11	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	6.79	4.24	1.09	0.00	0.61	0.36	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.28	3.96	0.82	0.14	1.23	0.82	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.11	3.27	1.48	0.11	0.32	0.63	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.01	7.11	0.53	0.00	0.53	1.32	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.63	7.31	0.66	0.00	1.33	0.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	6.80	2.72	0.91	0.00	0.00	0.45	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	3.79	2.27	0.00	3.03	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.79	3.94	1.42	0.16	0.95	0.32	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	7.88	4.85	2.12	0.00	1.21	0.91	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	10.03	5.08	0.76	0.00	0.63	1.02	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	9.85	4.85	1.21	0.00	0.91	1.06	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.31	3.89	1.34	0.13	0.54	0.67	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	4.75	5.18	0.86	0.43	0.00	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	11.72	2.93	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.53	6.69	2.31	1.61	0.92	0.69	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	8.82	3.05	1.53	0.00	0.34	0.51	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	2.58	3.05	0.00	0.00	0.23	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	8.02	4.25	0.94	0.00	1.89	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	3.26	2.42	0.24	0.00	0.48	0.24	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	10.97	4.07	0.90	0.23	0.68	1.02	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	13.78	4.54	1.05	0.70	0.52	0.35	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	13.64	7.63	0.97	0.32	0.49	0.16	0.49	0.32
Fibroblast - Gingival, donor1	11237-116D4	7.08	3.54	0.21	0.00	0.83	0.62	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	10.48	7.34	0.79	0.26	1.05	0.79	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	8.30	4.74	2.50	0.13	0.66	0.66	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	8.90	5.12	1.45	0.29	0.19	0.68	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	7.27	2.08	2.08	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	3.88	6.17	1.23	0.18	0.53	0.18	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.47	9.20	1.87	0.47	0.78	0.62	0.78	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.84	5.68	1.22	0.00	0.00	0.27	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	17.64	20.47	1.41	0.00	1.41	1.06	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	7.17	7.90	0.58	0.15	0.44	0.73	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	5.73	6.54	1.09	0.27	0.68	0.95	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	9.65	7.90	1.86	0.44	1.10	0.77	0.11	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.91	6.75	2.64	0.29	0.73	0.44	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	8.16	8.16	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	4.48	4.48	0.00	0.00	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	4.43	6.54	1.48	0.00	0.84	0.63	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	15.83	5.00	0.83	0.83	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	6.99	0.00	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.20	2.80	0.28	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	17.86	7.71	3.25	0.00	0.00	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	9.12	4.85	0.78	0.39	0.58	0.58	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.99	9.25	3.49	0.46	1.52	1.06	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.08	3.37	2.14	0.00	0.61	0.00	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	6.49	4.96	1.53	0.38	1.91	0.76	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	4.86	2.43	1.89	0.00	0.54	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	6.03	4.64	1.04	0.00	0.46	0.35	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	3.76	2.54	0.66	0.11	0.44	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	15.44	4.88	2.24	0.00	0.81	0.61	0.41	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.03	4.01	1.34	0.00	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1.98	3.56	0.00	0.00	0.40	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.86	9.53	1.19	0.00	3.97	2.78	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	3.73	3.02	0.36	0.18	0.18	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6.11	3.35	0.59	0.00	0.39	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	8.72	6.32	1.20	0.30	2.11	1.20	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	8.42	4.75	0.65	0.11	1.08	0.11	0.32	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.64	5.57	1.27	0.00	2.02	0.76	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	6.07	3.12	0.66	0.00	0.16	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	13.03	7.82	2.61	0.20	1.00	0.80	0.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	6.93	2.91	0.50	0.00	0.70	0.80	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.53	10.58	0.91	0.00	2.42	1.51	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	6.96	3.73	0.83	0.08	0.25	0.17	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	8.38	2.39	2.39	0.00	0.34	0.51	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	12.15	4.60	1.31	0.00	0.99	0.99	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.24	3.73	1.17	0.11	0.75	0.43	0.11	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	7.59	3.37	1.01	0.17	1.01	0.67	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1.88	1.73	0.78	0.00	0.78	0.16	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	20.92	0.00	0.00	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.89	2.43	0.52	0.00	0.35	0.00	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	6.51	1.56	0.26	0.00	1.04	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.13	5.88	1.02	0.51	0.51	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	9.95	4.59	1.53	3.06	4.59	3.83	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	15.31	1.91	1.91	3.19	6.38	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	34.80	15.69	5.13	0.86	5.13	4.85	4.28	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	71.42	38.05	6.34	0.55	8.00	6.89	0.28	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	49.09	34.25	6.85	0.91	3.88	3.20	2.05	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.42	21.00	2.58	0.20	5.15	3.96	4.16	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	65.82	32.25	7.40	0.53	6.61	4.76	0.00	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	49.25	39.79	9.13	0.65	5.54	3.26	3.59	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	33.17	15.92	3.54	2.21	3.98	5.31	3.54	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	22.05	6.22	4.95	0.57	2.54	1.13	1.70	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.34	5.54	6.77	1.35	2.09	0.99	1.23	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.92	8.86	4.03	0.54	1.61	0.54	3.22	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.23	7.81	2.35	0.37	1.73	0.37	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.58	5.26	2.91	1.25	1.80	0.14	1.25	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.50	4.88	1.42	1.83	1.63	1.02	2.44	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	8.21	7.76	2.74	0.00	1.37	1.60	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	22.67	5.61	5.48	0.37	1.25	0.12	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.11	6.56	4.15	0.44	2.19	0.66	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	9.46	6.80	2.36	0.00	0.30	0.30	0.89	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	22.41	8.74	5.25	0.64	2.07	0.32	0.32	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.20	8.71	4.02	0.00	1.79	0.22	1.79	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.32	9.07	2.62	0.20	2.02	0.40	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	20.53	7.63	4.58	0.68	1.53	0.34	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	14.36	9.58	5.76	0.44	1.60	1.06	0.53	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.49	11.97	7.28	0.31	0.52	1.14	0.52	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.51	8.71	5.29	0.85	0.68	0.51	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	20.03	6.42	4.09	0.11	2.66	0.33	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.15	8.15	3.41	0.25	0.67	0.67	0.67	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.03	8.78	3.68	0.00	1.02	0.82	0.00	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.08	6.40	3.92	0.00	0.83	1.03	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	22.02	7.72	3.92	0.35	2.08	0.35	0.12	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.34	7.00	1.83	0.17	1.33	0.83	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	10.36	7.05	2.65	0.00	0.66	0.66	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	19.31	8.98	4.55	0.12	1.48	0.49	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.83	10.05	3.08	0.32	1.46	0.49	0.65	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	13.79	8.34	2.57	0.00	1.92	1.28	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.94	6.54	3.79	0.28	0.95	0.76	0.28	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.92	8.86	3.16	0.00	1.27	0.63	0.47	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	12.77	10.64	3.95	0.00	0.91	0.30	0.00	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	13.38	6.17	3.76	0.00	1.67	0.21	0.21	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.05	5.05	1.10	0.22	0.88	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	12.62	7.01	4.49	0.00	1.12	0.00	0.28	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.07	6.48	2.59	0.09	1.67	0.46	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	6.69	4.81	1.60	0.00	1.07	0.53	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	10.71	7.65	1.07	0.00	0.46	0.46	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.67	5.44	1.94	0.13	0.52	0.78	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.39	4.61	2.44	0.54	0.81	0.54	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	11.06	7.37	1.66	0.18	0.74	0.00	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.28	5.70	4.82	0.00	0.66	0.88	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	22.81	7.93	7.93	0.00	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	8.18	4.22	2.51	0.00	0.66	0.40	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.68	4.84	1.61	0.20	0.40	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	6.86	5.85	6.86	0.25	0.25	1.27	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.08	7.76	5.97	1.39	2.79	2.19	1.79	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	29.89	7.70	5.85	1.85	2.47	1.08	1.85	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	41.73	12.48	6.75	1.02	3.48	1.02	3.07	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	13.46	2.19	1.25	1.56	2.82	1.25	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	15.26	6.22	1.98	1.13	1.98	1.98	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	24.91	7.38	3.23	0.46	3.23	1.84	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	29.70	14.85	0.00	9.90	2.47	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.02	15.09	7.74	0.77	3.09	2.71	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	33.69	0.00	0.00	6.42	3.21	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	27.82	6.96	0.00	5.22	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.53	12.04	3.58	0.00	2.93	1.30	1.95	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.47	16.47	2.88	0.41	3.71	0.00	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	33.32	19.99	0.00	6.66	3.33	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.90	16.78	2.24	0.28	1.40	2.52	0.56	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.38	18.30	3.60	1.31	1.63	1.63	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.13	14.26	5.03	0.84	3.36	1.68	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	20.67	20.04	3.50	0.32	2.54	1.59	0.64	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.61	13.93	1.70	0.00	1.36	2.04	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	8.35	2.09	0.00	2.09	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.60	15.46	4.58	0.57	0.57	2.86	1.72	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.32	11.25	5.03	0.00	2.66	2.37	0.30	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	6.78	6.78	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.08	13.25	4.14	0.00	2.49	1.66	0.41	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.34	14.96	5.52	0.00	1.38	1.84	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	5.27	5.27	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.45	16.53	2.69	0.38	1.92	2.31	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	13.69	14.02	1.96	0.65	0.65	1.96	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	8.03	1.34	0.00	0.67	0.67	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.11	9.25	3.08	0.00	3.47	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	19.17	27.73	9.93	0.68	3.08	4.45	0.68	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	24.85	2.48	0.00	2.48	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.35	15.57	6.13	0.00	1.89	1.42	0.47	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.05	13.28	3.02	0.60	0.60	1.81	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.77	15.77	2.03	0.00	3.05	2.03	1.02	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	24.33	18.35	5.18	0.40	1.99	0.80	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	13.32	4.44	0.00	2.47	1.48	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	21.25	14.17	4.72	0.00	1.18	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.34	9.92	3.50	0.00	2.33	1.17	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.36	6.14	7.46	0.00	0.88	1.76	0.88	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.95	11.87	13.56	0.00	5.93	0.85	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	13.13	6.57	0.60	4.18	0.60	0.60	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.28	11.65	4.85	0.00	1.46	0.49	0.00	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	5.71	0.00	0.00	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	5.41	0.83	0.00	0.00	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	1.12	0.00	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.39	1.59	1.59	0.00	0.00	0.63	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.92	0.84	0.42	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.03	0.23	1.39	0.46	0.23	0.12	1.04	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	6.25	0.51	0.84	0.51	0.51	0.17	1.01	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.01	0.23	0.91	0.23	1.14	0.00	0.91	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.79	0.55	1.53	1.42	0.33	0.11	0.77	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	6.45	1.07	1.07	0.86	0.00	0.43	1.93	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	5.17	0.43	1.94	1.29	0.43	0.00	1.08	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.11	0.00	1.37	0.50	0.12	0.00	1.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.92	0.69	0.86	0.34	0.00	0.17	1.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.20	0.96	1.60	0.64	0.00	0.32	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.43	7.83	2.24	0.00	1.12	1.12	1.68	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.98	7.79	1.73	0.87	0.43	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	5.29	0.00	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.70	6.00	1.76	0.35	1.06	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	8.72	1.45	0.73	1.45	2.18	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.07	3.32	0.35	0.00	0.52	0.17	0.17	0.00
Hepatocyte, donor1	11523-119I2	15.74	10.90	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	6.46	6.46	4.31	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	9.20	14.11	1.84	0.00	0.00	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	34.59	28.72	2.61	0.00	1.31	0.65	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	16.08	5.77	5.07	0.70	1.05	1.05	0.35	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.35	4.12	0.96	0.00	0.55	0.14	0.14	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	54.13	0.00	0.00	6.37	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	40.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	45.68	4.15	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	25.03	2.50	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	35.60	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	64.07	2.56	0.00	0.00	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	41.14	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	53.60	3.25	0.00	3.25	1.62	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	35.01	3.33	0.00	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	10.89	10.89	0.00	0.00	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	43.67	11.91	0.00	1.32	0.00	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	17.74	1.11	0.00	1.11	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	26.19	5.24	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	19.53	23.93	3.78	0.00	1.89	1.26	1.89	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	29.39	1.55	0.00	4.64	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	29.07	34.89	0.65	0.00	1.29	1.29	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	38.64	6.44	0.00	3.22	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	35.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	21.19	43.19	5.70	0.00	2.44	2.44	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	37.36	2.52	0.00	0.00	0.84	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.13	35.36	1.61	0.00	3.21	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	27.70	2.77	0.00	1.85	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	21.24	2.83	0.94	0.47	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	12.70	29.93	2.72	0.00	2.72	0.00	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	49.50	0.00	0.00	4.30	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	38.11	6.35	0.00	3.81	2.54	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	40.81	5.74	0.00	0.00	1.91	1.28	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	41.92	1.82	0.00	1.82	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	63.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	44.99	1.43	0.00	2.14	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	33.18	0.00	3.32	3.32	0.00	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	41.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.83	16.67	1.54	0.00	0.93	0.62	1.54	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	33.36	0.00	0.00	1.76	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	37.72	0.00	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	32.68	31.29	4.87	0.00	1.39	1.39	2.09	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	39.84	4.43	0.00	2.21	0.00	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	55.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	31.39	27.03	5.23	0.00	2.62	0.87	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	18.00	13.50	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	31.36	0.00	0.00	0.00	6.97	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	27.74	4.27	1.07	1.07	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	37.41	5.54	1.39	0.00	4.16	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	59.84	0.00	2.85	2.85	8.55	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	18.41	40.50	4.60	0.00	0.00	3.68	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	21.18	0.00	6.05	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	37.25	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	31.72	6.34	1.06	1.06	2.11	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	4.24	5.47	0.98	0.08	0.16	0.16	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	2.93	4.10	0.59	0.00	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.77	4.54	0.95	0.00	0.47	0.28	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	8.85	6.13	0.79	0.11	0.45	0.23	0.00	0.11
Keratocytes, donor1	11527-119I6	13.75	5.85	1.38	1.03	0.69	0.69	0.34	0.34
Keratocytes, donor2	11607-120I5	7.03	8.20	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	5.14	2.96	1.58	0.20	0.79	0.59	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	6.59	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	7.55	0.00	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	9.34	3.92	1.50	0.00	1.61	0.23	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	10.49	3.83	1.92	0.30	0.91	0.50	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.55	3.44	1.54	0.36	0.00	0.24	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.91	4.19	0.84	0.28	0.00	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.24	4.25	2.20	0.63	0.31	0.63	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	3.76	1.61	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.84	5.36	1.58	0.63	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.61	3.02	1.29	0.43	0.11	0.22	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.80	2.46	0.82	0.00	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.79	5.31	0.51	0.51	0.51	0.00	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.74	2.67	0.99	0.28	0.28	0.14	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.72	5.14	0.79	0.40	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.01	3.68	0.58	0.58	0.19	0.39	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.67	3.33	1.11	0.37	0.19	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.23	7.32	1.39	0.00	1.05	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.34	3.34	0.72	0.48	0.48	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.04	3.71	1.51	0.27	0.14	0.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.24	2.16	1.85	0.00	0.62	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.05	2.49	0.31	0.00	0.31	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.40	3.66	1.10	0.00	0.37	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.28	3.62	0.33	0.66	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.27	4.69	0.29	0.29	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.48	3.73	1.00	0.00	0.00	0.75	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	3.39	1.94	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.85	4.04	1.62	0.81	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.66	4.39	1.06	0.61	0.15	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	2.59	0.52	0.00	1.56	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.28	3.56	1.05	0.21	0.00	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.76	1.95	1.50	0.30	0.30	0.45	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	6.88	0.69	0.00	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.64	3.95	1.51	0.00	0.38	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.88	1.70	1.38	0.64	0.21	0.42	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.30	5.33	0.48	0.00	0.00	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.28	2.65	0.33	0.00	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.07	3.59	0.87	0.25	0.25	0.25	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	4.07	1.85	1.48	0.00	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.92	1.73	0.99	0.49	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.54	2.61	0.96	0.27	0.14	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.47	3.54	0.32	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.17	4.87	0.30	0.91	0.30	0.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	4.48	3.08	1.40	0.28	0.00	0.14	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	2.84	2.84	0.71	0.00	0.71	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	2.91	0.48	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.82	3.42	1.09	0.00	0.00	0.16	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.73	5.37	0.36	0.00	0.72	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.53	4.25	1.31	0.98	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	3.53	1.41	0.24	0.00	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.41	3.59	0.25	0.25	0.62	0.37	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.17	4.61	1.02	0.77	0.00	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.16	2.39	1.49	0.00	0.00	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	29.46	0.00	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	14.58	7.67	0.77	4.60	1.53	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	12.62	6.68	0.74	0.74	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.00	11.42	5.92	0.42	1.27	0.85	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	13.36	3.52	0.70	0.70	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	8.41	4.67	0.00	1.87	0.00	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	10.82	3.09	0.00	0.52	0.52	2.58	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	17.84	5.95	0.00	4.76	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.31	11.31	4.07	0.68	0.68	1.58	1.13	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.11	9.02	3.78	0.58	0.00	0.87	3.78	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.55	9.00	3.60	0.00	0.90	0.45	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.65	16.12	5.83	1.22	1.22	2.17	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	14.89	3.08	0.51	0.51	2.05	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.06	8.47	2.47	1.06	0.35	0.71	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.00	9.33	1.33	0.00	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.23	12.23	6.11	0.00	0.51	0.00	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.27	10.67	5.07	0.00	0.53	0.27	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.98	9.64	4.16	0.94	1.13	0.57	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.88	17.18	4.29	0.00	0.00	0.00	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	16.31	5.71	0.00	2.45	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.66	11.04	5.00	0.83	0.83	0.83	1.46	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.13	11.21	3.92	0.28	0.28	0.84	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	19.58	16.49	5.15	2.06	3.09	2.06	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	15.10	6.10	0.29	1.74	1.16	2.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.37	8.97	3.29	0.30	1.49	0.60	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.07	8.30	2.77	1.11	1.11	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.98	16.26	4.60	1.77	0.71	1.06	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.38	15.49	5.53	0.00	0.74	0.37	2.58	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	14.97	2.30	1.15	1.15	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.27	15.35	6.91	1.15	0.77	1.15	3.45	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.62	13.02	7.93	0.57	0.00	0.57	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	12.31	2.46	1.64	0.82	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	22.14	16.27	6.33	1.36	0.90	0.45	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.93	10.77	4.31	0.72	0.00	0.72	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	9.71	4.48	3.73	0.00	0.75	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.12	15.98	4.46	1.86	2.60	0.74	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.77	7.75	4.74	0.43	0.86	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	15.41	3.43	0.86	0.86	2.57	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.33	12.66	8.00	0.33	0.33	0.00	2.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.69	9.65	3.62	0.00	0.00	0.60	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	9.24	5.69	0.00	2.13	2.13	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.19	11.00	5.16	0.00	2.06	1.37	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.42	10.73	6.44	1.07	0.54	0.54	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	12.79	7.41	0.00	2.69	0.67	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.89	12.22	7.41	0.37	1.11	0.37	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	16.28	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	6.35	1.06	0.00	0.00	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.21	18.81	8.00	0.80	0.80	0.80	1.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	20.35	5.81	0.00	1.45	0.00	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	18.40	20.70	3.07	0.00	1.53	1.53	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.32	16.77	3.45	0.00	0.99	0.00	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	17.88	4.70	0.94	0.94	1.88	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.08	18.10	4.02	0.00	1.01	2.01	2.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.12	21.18	4.96	0.90	0.90	1.80	3.15	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	12.05	3.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.70	25.83	8.91	1.34	2.23	0.89	2.23	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	19.16	14.86	5.87	0.39	1.96	1.56	1.96	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	15.17	1.98	0.66	2.64	1.98	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.12	16.09	5.71	1.56	2.59	1.56	0.52	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.50	21.00	5.69	0.44	0.88	2.19	1.75	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	21.25	3.35	0.56	0.56	1.12	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.92	15.90	5.30	1.77	2.65	0.88	1.77	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.50	15.43	4.24	0.39	2.31	1.16	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.13	18.23	3.04	1.01	2.03	0.51	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	17.30	17.30	6.73	0.48	1.92	0.48	3.36	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.71	17.89	6.36	1.59	2.39	0.00	1.59	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.98	14.58	5.47	1.82	0.00	1.22	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	15.91	5.53	2.08	0.69	0.69	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.44	15.20	6.84	1.14	1.52	2.28	1.90	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.07	20.14	5.68	0.52	2.58	1.03	2.58	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	17.53	6.65	1.21	1.21	2.42	1.81	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.85	16.48	9.19	1.27	2.22	1.27	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.99	14.39	2.13	1.60	1.07	1.60	3.20	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	16.09	2.87	0.57	2.30	0.00	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.54	22.63	10.28	0.00	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.03	19.10	6.37	0.00	0.71	2.83	2.12	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	19.29	4.54	1.13	2.27	1.13	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	17.47	23.71	9.57	0.42	2.50	0.42	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	16.44	5.48	0.00	0.00	0.00	3.13	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.27	13.36	4.18	0.84	0.84	0.84	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.55	15.80	5.58	0.93	5.58	1.39	0.93	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	16.73	2.01	1.34	0.00	1.34	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	20.85	19.78	5.35	1.07	2.67	1.07	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	19.40	16.97	9.70	0.40	1.62	0.81	2.02	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	16.52	1.84	0.00	3.67	3.67	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	10.67	6.22	0.00	1.78	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	19.95	3.99	0.00	2.85	1.14	2.85	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	19.94	4.60	0.00	1.53	1.53	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.59	10.94	2.19	0.55	1.64	1.09	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	18.71	20.49	7.57	0.00	1.34	0.89	1.34	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.68	18.72	4.68	0.52	1.04	1.04	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	18.57	14.59	6.63	0.66	2.65	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	22.86	4.16	0.00	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	15.27	3.42	0.46	0.00	0.23	0.46	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.06	3.49	0.55	0.37	0.00	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	13.76	5.51	0.52	0.00	0.39	1.18	0.52	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1.06	2.12	0.00	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.45	2.85	0.79	0.16	0.32	0.79	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	5.28	2.78	0.97	0.14	0.42	0.00	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	4.58	3.59	1.49	0.10	0.50	0.40	0.40	0.00
Mammary Epithelial Cell, donor2	11350-117G9	6.37	1.74	0.29	0.00	0.00	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	8.98	6.73	0.25	0.50	0.25	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	6.78	1.36	0.00	30.51	0.00	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	30.71	13.63	3.89	0.43	1.30	1.30	0.76	0.32
Mast cell, donor2	11565-120D8	78.16	22.59	16.94	8.02	1.49	0.89	1.49	0.00
Mast cell, donor3	11566-120D9	90.50	16.88	21.84	11.48	2.25	2.25	2.25	0.90
Mast cell, donor4	11567-120E1	78.89	14.89	18.97	6.56	1.24	2.48	1.06	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	35.82	15.97	2.33	1.33	0.55	1.33	0.44	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	26.27	17.51	3.50	5.84	0.00	3.50	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	33.38	12.62	2.64	0.11	0.46	1.38	0.80	0.23
Mast cell, expanded, donor8	11941-126A6	58.24	20.59	2.01	0.67	0.84	2.34	2.51	1.00
Melanocyte - dark, donor1	11502-119F8	4.08	3.18	0.50	0.40	0.20	0.20	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	8.65	5.88	0.00	0.00	1.38	0.69	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	11.23	3.91	0.36	0.07	0.22	0.29	0.29	0.22
Melanocyte - light, donor1	11274-116H5	6.58	5.17	0.47	0.71	0.47	0.71	0.00	0.00
Melanocyte - light, donor2	11351-117H1	6.14	8.19	1.36	0.68	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	15.61	12.14	0.00	0.00	0.00	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.64	4.79	0.21	0.00	0.10	0.62	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	5.92	5.11	0.27	0.00	0.00	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	10.18	4.55	1.61	0.00	0.54	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	19.48	6.33	1.49	0.25	2.61	0.62	0.62	0.12
Meningeal Cells, donor2	11573-120E7	11.44	10.56	0.88	0.00	4.40	0.00	0.88	0.88
Meningeal Cells, donor3	11654-122E7	9.21	5.30	0.82	0.16	0.57	0.49	0.33	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.55	3.99	1.14	0.00	0.29	0.29	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.82	2.82	0.81	0.00	0.20	0.40	0.30	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	2.63	2.63	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	2.62	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.02	1.44	1.44	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.41	3.39	0.85	0.00	0.85	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	6.53	1.01	0.00	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.19	5.05	1.76	0.22	0.88	1.76	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	4.38	2.19	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.64	5.52	1.43	0.82	0.82	0.82	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.05	2.49	2.08	0.00	0.83	0.14	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.13	3.72	2.97	0.37	0.37	1.49	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6.32	2.37	1.05	0.13	0.53	0.53	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	3.86	2.37	0.00	0.59	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	7.01	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	8.33	0.64	0.64	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	3.19	2.13	0.35	0.00	1.06	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.19	3.13	0.31	0.31	0.31	0.31	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	1.45	0.73	0.00	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	5.04	1.06	1.06	0.00	0.27	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	4.00	1.00	0.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.20	2.17	1.95	0.14	0.72	0.29	0.00	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	10.80	0.00	0.00	1.35	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	2.46	0.49	0.74	0.00	0.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.18	4.12	0.29	0.88	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.44	1.55	0.31	0.31	0.00	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.94	2.70	0.00	0.21	0.00	0.41	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	4.63	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.01	2.00	1.00	0.00	0.25	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	5.59	4.65	0.00	0.00	0.47	1.40	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.86	2.64	0.41	0.41	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.96	1.19	0.40	0.40	0.40	1.19	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	0.88	0.88	0.00	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.66	2.66	0.76	0.76	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	1.32	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.61	1.06	0.00	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	2.76	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.98	0.89	0.60	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	3.35	1.68	1.68	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.26	1.00	0.25	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.61	3.09	0.71	1.19	0.24	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	0.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.92	0.69	0.23	0.23	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.10	1.26	0.21	0.63	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.65	1.02	0.41	0.20	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.93	1.07	0.21	0.21	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.78	0.22	0.22	1.11	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.19	0.00	0.44	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	1.01	0.00	0.00	0.51	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.08	1.36	0.54	0.27	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.82	0.88	0.00	0.59	0.00	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	0.00	0.48	0.48	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	0.40	0.40	1.60	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	1.37	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	2.00	0.00	2.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04	0.00	6.12	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.57	0.44	0.00	2.19	0.88	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	1.10	0.00	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	2.56	0.64	2.56	0.00	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.20	2.23	0.50	3.22	0.99	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	0.70	1.39	1.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	4.42	0.00	2.21	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	4.10	1.03	0.68	2.39	0.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	2.63	0.00	0.44	0.44	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.75	4.62	1.07	3.55	1.42	0.71	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.42	1.96	1.68	2.52	0.84	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	0.00	0.42	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	2.33	1.17	1.17	1.75	0.58	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	1.81	1.21	2.71	0.60	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.43	0.00	0.42	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	0.92	0.00	1.85	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	2.85	1.14	0.57	0.57	1.14	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.02	2.35	0.55	1.38	0.28	0.41	0.28	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.81	1.55	0.78	1.55	1.30	0.26	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.58	2.14	0.00	1.72	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	1.91	1.91	1.91	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	2.40	0.80	0.80	0.80	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.08	3.89	1.80	0.00	0.00	1.20	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.17	1.55	0.71	1.55	0.57	0.42	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.37	1.91	0.64	0.32	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.29	1.99	0.88	1.33	1.11	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.13	2.65	0.00	2.28	0.76	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.81	2.84	0.57	1.42	0.28	0.57	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.31	1.47	0.00	0.49	0.49	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	5.21	0.65	1.30	1.30	1.30	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	1.47	0.59	1.47	0.29	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.24	1.44	1.44	0.00	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.78	2.47	3.30	0.41	0.00	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	3.28	0.89	0.89	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	3.29	0.66	0.00	0.00	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	3.16	1.05	1.05	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.70	3.76	0.99	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	3.73	0.00	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.39	3.76	0.38	0.38	0.00	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.66	4.00	0.80	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.24	3.51	0.23	0.00	0.23	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	0.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.16	3.30	1.10	0.00	0.00	1.10	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	3.11	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.37	1.26	0.84	0.84	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00	2.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	1.51	0.00	0.00	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	17.13	0.00	22.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	9.79	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	4.75	0.00	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	12.55	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.96	3.23	1.29	0.22	0.65	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.93	4.18	3.14	0.00	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	1.33	6.01	1.33	0.67	1.33	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.50	8.35	0.83	0.00	0.42	2.09	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4.56	28.14	0.95	0.00	1.14	1.52	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	7.98	1.60	0.00	1.60	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	2.72	0.68	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	18.38	1.84	0.00	3.68	9.19	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.93	3.77	0.84	0.00	0.42	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.25	4.88	0.93	0.00	0.93	0.70	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.43	4.59	0.00	0.00	0.00	1.62	0.27	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.52	6.10	0.42	0.21	0.42	0.42	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.98	2.98	0.50	0.00	0.00	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.17	7.58	0.27	0.27	0.27	0.81	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.95	2.72	0.68	0.23	0.00	0.68	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	1.96	6.70	0.65	0.00	0.16	1.47	0.16	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	4.92	4.01	0.73	0.00	0.18	0.36	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.24	8.49	0.00	0.00	0.00	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	3.60	0.00	0.00	0.00	1.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	3.61	16.74	1.31	0.00	0.98	0.98	0.00	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.09	3.74	0.65	0.00	0.33	0.98	0.33	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.41	5.12	0.71	0.18	0.71	0.53	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.81	1.41	0.00	0.00	0.00	0.70	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.14	6.44	0.46	0.00	0.46	0.92	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.18	4.82	0.32	0.00	0.32	0.96	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2.07	13.80	2.41	0.00	0.34	1.38	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	37.93	0.00	0.00	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	3.12	4.90	0.45	0.00	0.89	1.11	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	4.23	0.85	0.00	0.85	1.69	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.80	9.73	0.47	0.24	0.24	0.71	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	4.72	4.29	0.00	0.00	2.15	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	18.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.33	7.33	0.33	0.00	0.00	1.00	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	3.61	2.25	0.00	0.00	0.00	0.90	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	1.19	4.36	0.00	0.00	0.00	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	8.36	1.86	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.57	6.43	0.76	0.00	1.14	0.76	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.24	4.24	0.98	0.33	0.33	1.30	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.23	1.74	0.44	0.00	0.87	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5.43	4.52	0.45	0.00	1.36	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	6.17	0.00	0.00	0.88	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	1.99	5.32	0.00	0.00	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	4.46	1.49	0.00	0.50	1.49	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	4.59	0.38	0.00	0.77	2.68	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.77	8.77	0.91	0.00	0.91	2.12	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	4.86	3.09	1.11	0.22	0.44	1.11	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	0.68	1.36	0.00	0.00	0.00	0.68	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	5.11	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.05	4.88	0.00	0.00	0.61	1.83	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.46	7.24	0.94	0.31	0.00	1.26	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.03	5.45	1.21	0.00	0.30	0.91	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2.37	4.75	1.58	0.00	0.00	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	15.87	1.13	0.00	0.00	4.53	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	10.12	0.00	0.00	0.00	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	3.60	1.24	0.87	0.00	0.50	0.37	0.00	0.00
Myoblast, donor2	11322-117D8	7.10	4.41	0.96	0.00	0.19	0.38	0.00	0.58
Myoblast, donor3	11398-118D3	5.04	3.36	1.01	0.00	0.50	0.67	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	30.21	6.57	1.90	6.28	0.44	0.73	0.58	0.58
Natural Killer Cells, donor1	11230-116C6	64.58	14.76	6.15	10.15	0.31	0.62	1.23	1.23
Natural Killer Cells, donor2	11311-117C6	58.20	14.78	9.35	10.86	0.00	0.90	1.51	0.60
Natural Killer Cells, donor3	11387-118C1	54.85	13.80	6.63	11.04	0.92	1.29	0.74	0.92
Neural stem cells, donor1	11275-116H6	12.34	12.70	7.98	1.81	1.09	0.36	1.45	0.36
Neural stem cells, donor2	11352-117H2	17.33	3.85	0.00	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	25.03	5.69	4.55	0.00	2.28	1.14	0.00	3.41
Neurons, donor2	11574-120E8	15.19	8.37	4.62	0.44	1.10	0.44	0.00	0.22
Neurons, donor3	11655-122E8	13.98	13.98	5.76	0.00	1.64	0.82	2.47	2.47
Neutrophils, donor1	11233-116C9	47.33	1.86	22.27	4.64	0.00	2.78	1.86	0.00
Neutrophils, donor2	11314-117C9	63.78	2.90	40.58	2.90	0.00	8.70	0.00	2.90
Neutrophils, donor3	11390-118C4	77.58	4.28	22.60	9.77	0.61	1.22	3.05	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	7.48	5.22	2.97	0.00	0.47	0.71	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	6.84	4.23	2.28	0.33	0.00	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	5.01	2.41	0.40	0.20	0.80	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	6.06	4.96	0.55	0.41	0.41	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	3.33	4.34	0.87	0.14	0.43	0.58	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	4.43	4.31	0.79	0.00	0.11	0.34	0.11	0.23
Olfactory epithelial cells, donor4	11936-126A1	8.18	5.55	0.78	0.00	0.68	1.07	0.19	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	4.81	1.81	0.60	1.20	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.04	3.40	0.43	0.21	0.21	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	4.57	3.43	0.00	0.00	0.00	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	9.31	3.72	0.62	0.00	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	6.64	3.13	1.17	0.00	0.59	0.20	0.00	0.20
Osteoblast, donor2	11354-117H4	3.51	4.21	1.40	0.70	1.40	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	9.60	5.87	1.07	0.18	1.78	0.00	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	6.15	3.62	0.93	0.17	0.42	0.08	0.17	0.08
Pericytes, donor1	11491-119E6	10.57	5.23	0.33	0.11	1.00	0.89	0.11	0.22
Pericytes, donor2	11571-120E5	10.41	4.30	2.26	0.00	1.58	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	9.56	3.46	1.83	0.41	0.61	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	3.16	2.94	1.58	0.34	0.79	0.11	0.00	0.11
Perineurial Cells, donor2	11579-120F4	10.95	3.31	1.10	0.00	0.46	0.83	0.00	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.34	13.39	3.82	6.69	2.23	0.96	1.27	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	40.40	12.98	3.43	2.94	0.49	1.22	1.22	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.37	14.49	6.34	2.46	0.65	0.91	1.68	0.78
Placental Epithelial Cells, donor1	11278-116H9	6.22	3.59	3.11	0.48	0.48	0.96	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	6.65	3.33	1.11	0.00	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.87	6.28	3.53	0.98	0.79	0.39	0.59	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.85	2.22	0.32	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	3.94	3.00	1.13	0.00	0.38	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.75	4.44	1.44	0.00	0.78	0.78	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	4.50	3.38	1.35	0.00	0.23	0.23	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	3.09	2.34	0.85	0.11	0.00	0.21	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	5.67	2.18	0.87	0.44	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	4.73	3.72	1.86	0.00	0.57	0.29	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	2.95	2.95	1.97	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.84	4.61	0.92	0.31	0.92	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	4.43	6.37	2.30	0.71	0.71	0.35	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	3.24	4.43	0.68	0.00	0.34	0.17	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	5.22	4.84	1.30	0.47	0.28	0.47	0.00	0.09
Preadipocyte - visceral, donor2	11357-117H7	5.52	3.68	2.30	0.00	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	3.97	4.60	0.73	0.10	0.42	0.42	0.42	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	13.28	6.18	5.13	0.91	0.91	0.75	0.60	0.60
Prostate Epithelial Cells, donor2	11331-117E8	7.45	3.52	2.30	0.14	0.27	0.54	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	5.76	3.86	0.80	0.06	0.06	0.67	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	5.70	2.85	1.48	0.23	0.68	0.34	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	8.25	3.94	1.79	0.18	1.08	0.54	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	5.11	3.44	2.09	0.21	0.94	0.83	0.00	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.15	3.28	2.55	0.00	0.73	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.39	3.88	0.76	0.28	0.28	0.07	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	18.26	7.61	1.01	0.51	1.01	0.51	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	22.05	6.40	5.69	0.00	0.71	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.58	3.07	1.48	0.00	0.21	0.42	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	4.77	1.36	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.89	3.77	0.94	0.13	0.94	0.40	0.13	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.10	5.55	0.89	0.22	1.33	0.67	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	8.65	0.67	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	12.77	4.84	2.42	0.44	1.10	0.44	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	16.93	6.90	3.76	0.63	1.25	0.63	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	14.70	4.44	1.66	0.28	1.39	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.35	5.10	0.81	1.07	0.27	1.34	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	7.59	3.80	1.27	1.27	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.51	7.33	2.31	0.77	0.77	0.58	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.07	4.15	1.04	0.00	1.56	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.92	7.67	1.99	0.28	0.57	0.28	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	4.12	2.06	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	5.77	3.51	0.50	0.25	0.25	0.25	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	18.04	5.21	3.21	0.40	0.67	1.07	0.94	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	14.29	2.68	1.79	0.00	1.79	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	17.06	14.86	1.10	0.00	0.55	3.30	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.08	16.24	2.32	0.00	1.16	0.58	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	19.37	15.47	1.69	0.26	1.56	1.69	0.65	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	16.39	17.58	2.18	0.30	1.19	1.09	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	20.30	14.61	1.56	0.22	0.45	0.56	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.98	15.75	3.23	0.37	1.36	0.87	1.24	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	19.35	18.06	3.26	0.12	1.05	0.82	1.05	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.10	18.03	2.77	0.46	0.92	1.16	0.92	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.08	13.96	2.46	0.96	1.51	1.64	1.51	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.64	16.64	1.82	0.61	0.45	1.66	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.56	15.59	1.79	0.18	1.43	0.54	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	16.21	14.92	1.72	1.00	1.29	1.29	0.29	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.17	15.24	1.72	0.21	0.32	0.54	0.97	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	14.16	17.04	2.88	0.66	0.66	1.99	1.55	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	19.50	16.06	0.57	1.34	2.68	1.72	0.96	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.26	15.56	2.14	0.84	0.93	1.02	1.02	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	17.85	15.22	2.44	0.56	0.38	0.94	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.38	13.93	2.39	0.53	1.33	1.06	1.59	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.80	14.89	2.63	1.07	0.97	1.46	0.97	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.09	17.95	2.86	0.38	0.95	1.34	0.57	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.37	14.42	2.03	0.43	0.64	1.60	1.60	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.02	14.58	3.92	0.84	0.28	1.12	1.96	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.87	15.04	3.42	0.17	0.51	1.54	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.13	14.59	1.64	0.91	1.28	1.64	1.09	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.26	17.78	2.45	1.23	1.23	0.86	1.35	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	15.31	18.13	1.75	0.81	1.07	1.34	1.07	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.09	13.44	2.83	1.42	0.94	1.89	0.47	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.92	15.87	3.37	1.79	0.60	0.60	1.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	16.37	19.18	1.40	0.00	0.94	0.94	0.94	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.14	17.21	2.28	0.41	2.07	2.49	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.95	16.37	2.88	1.77	0.00	0.22	0.44	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	13.58	23.60	3.97	2.30	0.42	1.25	1.88	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	18.17	16.69	4.58	1.21	2.02	1.75	0.94	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.65	18.73	3.24	1.02	1.19	2.55	2.21	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	18.70	17.93	1.74	1.35	1.93	1.16	1.54	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.84	14.61	3.44	1.38	2.41	1.72	1.20	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	17.42	17.15	3.02	1.23	1.37	0.55	1.65	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.75	14.78	2.96	0.16	1.64	0.82	1.64	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.60	15.17	2.05	1.02	1.19	1.02	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	9.77	14.06	3.70	0.89	0.59	0.74	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.59	16.26	2.40	0.27	1.33	1.33	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.87	13.41	2.63	0.41	1.66	0.69	1.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.43	13.57	2.62	0.24	0.00	1.19	1.67	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	23.38	20.36	3.83	0.60	0.40	1.41	1.01	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	19.87	16.10	1.79	0.57	1.13	1.98	1.70	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	15.37	16.77	5.24	0.00	0.00	2.10	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.04	16.32	1.81	0.91	0.91	1.81	0.30	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.38	14.56	1.96	0.00	1.22	1.84	0.73	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	35.08	44.25	6.26	1.60	1.31	3.49	1.16	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.21	22.51	1.83	0.00	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.45	9.95	0.60	0.90	0.60	2.11	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	20.81	22.62	2.71	0.23	0.45	2.04	1.13	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.76	21.27	3.59	0.30	0.90	3.59	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	18.77	22.08	3.90	1.06	1.18	1.18	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.53	19.64	2.99	0.21	1.49	1.71	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	40.87	18.03	3.00	0.60	1.20	1.20	0.60	0.60
Schwann Cells, donor1	11498-119F4	12.60	5.27	2.44	0.00	2.44	1.69	0.19	0.00
Schwann Cells, donor2	11578-120F3	20.41	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.67	3.07	1.10	0.00	0.88	1.53	0.66	0.00
Sebocyte, donor1	11220-116B5	10.96	4.93	4.38	0.00	0.00	0.00	2.19	0.55
Sebocyte, donor2	11301-117B5	11.03	6.43	4.14	0.00	0.92	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	5.57	4.12	1.24	0.00	0.21	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	0.00	6.63	1.66	0.00	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	5.65	0.00	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	3.17	6.16	1.58	0.18	0.35	0.53	0.09	0.18
Skeletal Muscle Cells, donor2	11358-117H8	5.06	4.34	1.45	0.00	1.45	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	13.38	10.03	1.67	0.00	4.18	2.51	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	6.60	7.07	0.94	0.16	1.57	0.79	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	7.13	4.16	0.74	0.15	1.19	1.04	0.15	0.30
Skeletal Muscle Cells, donor6	11459-119B1	14.01	4.46	1.08	0.15	1.69	0.15	0.92	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	6.80	5.92	2.39	0.13	0.88	0.88	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.42	5.85	1.28	0.14	1.00	0.71	0.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	9.72	6.94	1.59	0.50	2.38	0.79	0.69	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	3.88	4.97	1.43	0.08	0.25	0.42	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	5.79	1.45	0.00	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.95	3.16	0.83	0.14	0.28	0.14	0.14	0.28
Skin - palm, donor1	10286-104F7	24.17	16.12	0.00	2.69	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.62	5.62	0.14	0.00	0.43	0.86	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	24.54	21.27	4.91	0.82	2.45	0.00	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.06	5.97	0.65	0.26	0.26	0.26	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	6.12	4.31	0.83	0.00	0.28	0.42	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	7.74	5.63	0.98	0.14	0.98	0.28	0.70	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	21.99	15.86	2.11	1.48	1.06	0.85	1.27	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	10.19	4.80	1.87	0.30	0.60	0.45	0.15	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2.78	0.31	0.31	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.89	2.45	0.89	0.00	0.67	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.82	9.41	0.59	0.00	0.59	1.76	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.93	4.86	1.77	0.00	1.55	0.44	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.51	1.58	1.18	0.39	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	3.09	0.77	0.77	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	8.01	7.01	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.32	1.73	0.67	0.00	0.53	0.27	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	2.44	2.44	1.33	0.00	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.79	1.41	0.38	0.00	0.13	0.26	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	3.91	2.60	1.30	0.00	1.30	0.65	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	5.02	5.61	1.18	0.00	1.18	1.18	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.55	2.99	0.85	0.14	0.71	0.28	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.32	2.60	1.79	0.65	0.49	0.65	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	6.70	4.26	1.83	0.00	1.22	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.12	4.80	1.01	0.00	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	110.17	30.60	6.12	6.12	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	5.25	0.00	0.00	0.95	0.00	0.48	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	4.72	3.39	1.18	0.00	0.59	0.29	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.82	3.87	1.72	0.43	0.22	0.43	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	6.61	2.73	0.73	0.00	1.15	0.31	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.95	2.94	0.77	0.15	1.24	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	3.23	0.00	1.08	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.38	2.69	0.90	0.30	1.79	0.30	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.63	2.39	1.02	0.00	0.34	0.34	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.95	3.22	1.02	0.08	0.31	0.00	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	2.72	3.82	1.11	0.10	0.10	0.60	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	6.60	2.50	1.59	0.23	1.37	0.46	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	3.02	1.81	0.00	3.02	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.19	3.97	1.32	0.26	0.53	0.00	1.06	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	6.39	4.79	1.33	0.13	1.46	0.27	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	7.64	5.38	2.00	0.25	0.25	0.63	0.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.03	3.04	1.01	0.00	0.00	0.76	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.39	3.02	1.21	0.00	0.45	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	6.75	1.50	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	38.77	29.72	6.46	1.29	7.75	2.58	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	6.51	1.40	0.00	1.40	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1.51	3.03	1.51	0.00	0.00	0.00	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	2.19	0.63	0.63	1.25	0.63	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	2.36	1.18	0.00	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7.00	2.00	0.75	0.17	0.83	0.17	0.58	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	4.20	3.27	0.00	0.47	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.62	1.30	0.58	0.14	0.43	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.92	2.04	1.78	0.51	1.02	0.25	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.45	2.44	0.38	0.19	0.75	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.69	4.05	1.82	0.14	0.28	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.69	2.09	1.34	0.08	0.59	0.17	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	3.81	0.48	0.00	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.58	2.94	0.98	0.00	1.22	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	4.42	3.54	1.55	0.22	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.10	3.51	1.17	0.00	0.29	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.80	4.86	0.97	0.00	0.78	0.19	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.97	3.17	0.79	0.00	0.53	1.32	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.35	1.86	2.60	0.00	0.37	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	2.87	2.87	1.08	0.36	0.00	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.54	3.41	0.85	0.00	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.30	4.73	0.00	0.00	0.39	0.79	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	6.60	3.30	1.52	0.00	0.51	0.51	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	6.39	5.19	1.60	0.00	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	3.76	4.18	0.84	0.00	0.42	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	1.38	1.38	0.00	0.00	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	2.36	3.53	1.18	0.17	0.17	0.00	0.17	0.00
Synoviocyte, donor2	11368-117I9	4.02	3.02	1.01	0.00	0.00	0.34	0.00	0.17
Synoviocyte, donor3	11440-118H9	4.47	3.35	1.34	0.00	0.22	0.22	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	18.22	10.72	1.43	0.36	0.71	0.71	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.87	7.64	2.08	0.46	0.69	0.69	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	6.67	2.94	0.22	0.00	0.07	0.14	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	5.03	0.00	0.00	0.77	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	8.02	1.15	0.00	0.00	0.57	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.31	7.87	2.83	0.12	0.74	1.35	0.49	0.12
Urethra, donor2	10319-105A4	32.37	26.98	1.80	3.60	0.00	0.00	5.40	0.00
Urothelial Cells, donor1	11520-119H8	10.63	1.59	1.06	0.27	1.33	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	10.01	2.00	0.80	0.00	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	9.17	3.90	0.92	0.00	0.46	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	8.69	2.45	1.34	0.00	0.67	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.93	11.57	6.23	0.00	2.67	1.78	3.56	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	52.90	5.72	7.15	4.29	0.00	1.43	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	39.02	8.21	8.21	1.37	0.68	0.68	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.55	13.08	5.85	2.41	0.34	0.34	2.41	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	45.90	15.69	9.30	4.65	0.58	1.74	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	44.77	12.49	7.29	1.04	0.00	4.16	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	52.31	9.18	4.59	0.92	0.00	0.00	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	45.64	7.30	2.74	0.00	1.83	0.91	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.74	10.36	4.44	0.12	2.34	1.48	0.86	1.11
Wilms' tumor cell line:HFWT	10597-108E3	8.80	2.64	1.76	0.00	2.64	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.20	10.33	1.40	0.00	1.96	0.84	0.56	0.28
achilles tendon, donor2	10292-104G4	20.67	10.33	4.13	0.00	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.42	13.26	5.35	3.06	0.00	0.25	0.51	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	31.81	22.99	3.48	0.46	0.93	1.39	2.32	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	72.77	35.97	5.70	1.42	2.14	1.66	2.97	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	38.64	16.33	4.35	0.82	1.90	1.09	2.18	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.05	14.34	2.53	1.41	0.56	0.28	0.56	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.40	20.30	1.27	1.27	0.85	0.00	1.27	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.04	18.51	1.91	2.99	0.82	1.09	4.08	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	29.52	14.10	2.20	1.32	1.76	0.88	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	19.19	24.09	0.41	2.04	0.41	0.41	0.41	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.22	19.03	5.05	4.27	5.05	0.78	0.39	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	15.27	17.66	2.02	0.55	0.55	0.92	1.29	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	19.50	3.90	0.00	0.00	3.90	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.71	11.39	3.02	0.23	0.46	0.70	1.39	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	25.37	21.23	2.59	0.52	3.11	1.55	1.04	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	30.98	22.21	2.05	0.29	2.34	1.46	2.05	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.38	16.73	1.39	0.93	2.32	1.39	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.87	13.98	1.65	0.00	0.41	0.41	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.51	18.11	1.23	0.31	0.31	0.92	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	21.76	17.50	3.41	1.28	0.85	1.28	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.75	13.65	0.91	0.61	0.61	1.52	0.91	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	19.74	14.20	3.37	1.93	1.44	0.96	0.24	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.94	11.58	1.56	0.45	0.45	0.89	0.45	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.68	11.01	2.00	0.33	0.33	1.00	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	13.01	7.43	1.86	3.72	0.00	7.43	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.94	11.30	1.88	0.00	0.00	0.75	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	66.73	27.91	3.49	5.23	1.74	1.31	4.36	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	39.36	7.50	3.75	9.37	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	31.79	11.54	0.71	0.71	0.00	1.41	1.88	0.00
adipose tissue, adult, pool1	10010-101C1	16.60	11.32	4.50	0.47	1.09	1.09	0.16	0.47
adipose, donor1	10184-103D4	46.33	36.36	10.56	0.00	12.90	0.59	0.59	1.17
adipose, donor2	10185-103D5	40.96	27.98	6.89	0.41	8.11	1.62	1.22	1.62
adipose, donor3	10186-103D6	57.18	31.04	5.72	0.54	5.17	3.00	1.91	2.45
adipose, donor4	10187-103D7	113.54	65.01	13.00	3.47	8.67	6.07	7.80	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.83	6.15	4.42	0.79	3.31	0.16	2.37	0.32
adrenal gland, adult, pool1	10081-102A9	25.46	7.28	0.00	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	27.21	16.14	1.60	1.33	0.53	2.27	1.07	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.44	6.79	1.79	0.36	1.07	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	15.53	4.87	1.16	0.00	0.23	0.70	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	21.64	12.85	3.04	0.00	1.69	1.01	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	9.43	5.89	0.59	0.00	0.29	1.18	0.29	0.29
amygdala - adult, donor10196	10167-103B5	11.86	5.93	4.74	0.00	1.19	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	21.70	11.35	6.08	0.00	1.01	1.42	2.03	1.82
amygdala, newborn, donor10223	10360-105E9	17.43	8.71	1.94	1.94	1.61	2.26	1.94	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	8.79	3.31	4.20	0.76	0.64	0.13	0.13	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.55	9.49	1.76	0.22	1.32	1.10	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	83.18	46.77	9.69	1.67	3.34	0.67	2.00	7.35
aorta, adult, pool1	10052-101G7	25.11	4.90	3.33	0.39	1.37	1.77	0.00	0.20
appendix, adult	10189-103D9	37.26	16.30	6.60	3.49	1.55	1.16	0.39	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	19.60	6.19	7.57	0.69	0.69	2.75	2.41	0.69
artery, adult	10190-103E1	6.79	5.43	4.08	0.00	1.36	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	15.07	8.69	3.19	0.87	0.72	0.43	0.72	0.58
b cell line:RPMI1788	10427-106D4	19.78	6.10	1.34	21.56	0.74	0.74	0.89	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.72	1.39	2.50	0.00	0.28	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	15.38	4.96	1.89	2.08	0.99	0.50	0.60	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	10.71	2.68	1.34	0.33	0.33	0.33	1.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	33.00	16.78	2.24	0.56	1.68	2.24	0.00	1.68
bladder, adult, pool1	10011-101C2	19.01	7.17	3.69	0.65	0.98	0.65	0.22	0.22
blood, adult, pool1	10053-101G8	17.72	11.07	0.00	2.21	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	6.85	11.99	0.00	0.00	0.86	0.00	0.00	0.86
bone marrow, adult	10192-103E3	5.40	5.40	4.05	0.67	0.00	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	28.70	9.23	3.08	0.00	1.03	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	17.71	6.68	5.12	0.22	1.34	0.89	0.56	1.00
brain, fetal, pool1	10085-102B4	45.41	8.01	5.34	0.00	2.67	0.00	10.69	2.67
breast carcinoma cell line:MCF7	10482-107A5	14.87	5.95	3.30	1.32	2.64	0.00	1.98	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	35.32	21.47	2.87	0.50	0.75	1.37	0.62	1.12
breast, adult, donor1	10080-102A8	29.67	5.68	2.53	0.00	0.63	2.53	0.00	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.80	8.38	2.92	1.02	0.00	0.00	2.67	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.26	17.32	2.16	1.86	0.62	0.62	0.93	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.65	1.61	1.61	1.15	0.23	0.00	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.20	12.10	0.73	0.00	0.00	0.24	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	23.98	15.99	0.94	0.00	0.00	0.94	0.00	1.88
carcinoid cell line:NCI-H727	10735-110B6	18.81	5.47	2.30	2.41	1.20	0.22	1.64	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	12.04	12.36	1.58	0.00	0.63	0.63	0.32	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	21.29	12.51	3.46	0.80	2.93	0.80	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	20.72	12.66	12.66	0.00	2.30	1.15	4.61	1.15
caudate nucleus, adult, donor10252	10164-103B2	16.90	6.19	4.35	0.33	1.00	2.51	0.84	1.00
caudate nucleus, adult, donor10258	10379-105H1	12.99	9.93	1.53	0.00	0.00	0.76	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	27.83	11.35	2.56	1.46	0.00	4.03	3.66	0.73
cerebellum - adult, donor10196	10173-103C2	34.96	20.39	14.57	2.91	2.91	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	31.81	20.92	8.97	0.43	1.92	1.71	4.70	3.63
cerebellum, adult, pool1	10083-102B2	20.01	14.83	2.41	0.00	0.34	0.69	1.72	1.03
cerebellum, newborn, donor10223	10357-105E6	52.31	16.61	3.32	0.83	2.49	1.66	4.15	1.66
cerebral meninges, adult	10188-103D8	11.60	5.29	1.76	0.00	1.01	1.26	0.76	0.76
cerebrospinal fluid, donor2	10294-104G6	10.23	3.65	1.46	0.00	0.00	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	9.06	0.86	2.16	1.73	0.00	0.00	0.72	0.00
cervical cancer cell line:ME-180	10553-107I4	12.10	1.33	3.31	1.16	0.50	0.33	0.99	0.00
cervix, adult, pool1	10013-101C4	25.93	13.44	8.19	0.63	1.05	1.15	0.31	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	5.43	2.37	0.84	0.14	0.28	0.28	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	7.84	0.00	0.00	0.00	3.92	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	17.52	12.43	3.60	0.12	0.50	1.37	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	15.65	6.65	2.22	0.49	0.74	0.49	2.34	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	28.46	14.23	1.90	0.47	0.24	1.42	1.42	0.00
chorionic membrane cells, donor1	12238-129G6	11.40	4.56	3.42	0.28	0.00	0.00	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	11.83	6.26	1.89	0.20	0.99	0.80	0.10	0.30
chorionic membrane cells, donor3	12240-129G8	8.24	3.30	3.85	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	8.08	3.03	1.01	0.00	2.02	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.94	12.10	1.73	0.00	0.96	0.77	1.54	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.89	31.04	3.17	1.27	1.06	0.63	0.42	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.65	8.22	4.62	0.51	0.26	0.51	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.38	11.85	2.90	0.97	1.21	0.73	0.97	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	19.34	9.77	3.46	0.81	1.02	0.41	0.81	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	20.61	12.07	1.77	0.29	2.36	0.59	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	45.87	29.97	3.91	3.65	1.04	2.09	2.35	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	17.37	2.97	2.51	3.89	0.00	0.46	1.37	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.33	3.64	2.08	2.26	0.69	0.35	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	13.91	5.67	1.46	2.20	0.37	0.18	0.55	0.55
colon carcinoma cell line:COLO-320	10420-106C6	25.85	20.90	5.70	0.38	0.38	0.76	0.38	0.76
colon, adult, donor1	10082-102B1	29.75	19.04	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	34.78	13.28	2.94	0.47	1.76	1.76	0.82	0.47
colon, fetal, donor1	10070-101I7	24.10	5.56	3.09	0.00	0.00	0.00	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	82.50	187.92	18.33	4.58	4.58	9.17	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	36.12	8.50	4.25	40.79	0.42	0.85	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	18.41	10.11	1.66	16.90	1.06	0.30	0.91	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	18.33	11.00	2.12	14.24	0.56	0.42	0.99	0.00
corpus callosum, adult, pool1	10042-101F6	32.39	8.96	14.04	1.44	2.43	1.55	1.55	1.88
cruciate ligament, donor2	10295-104G7	20.26	12.16	1.62	1.62	2.43	1.62	4.05	0.00
diaphragm, fetal, donor1	10069-101I6	9.63	2.41	2.41	0.80	0.80	1.61	0.00	1.61
diencephalon, adult	10193-103E4	11.04	4.08	2.88	0.96	1.20	0.24	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	32.83	30.31	3.44	1.61	0.46	0.46	1.38	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	0.51	1.80	3.08	0.26	0.26	2.31	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	3.61	1.69	0.24	0.48	0.00	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	26.41	15.45	4.49	0.50	1.50	1.50	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	10.08	2.88	1.44	1.44	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.07	10.30	11.03	0.00	0.00	3.68	2.21	0.00
dura mater, adult, donor1	10041-101F5	28.66	11.73	3.63	0.66	1.73	1.40	0.50	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	7.11	14.88	2.22	11.33	0.22	2.00	0.67	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	11.46	10.89	2.15	0.43	0.72	1.29	0.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	9.87	5.55	0.00	0.00	1.85	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	6.36	3.94	0.61	0.00	0.91	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.28	6.17	0.93	0.31	0.31	0.93	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	17.08	7.88	1.31	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.72	4.36	3.02	1.34	3.35	0.00	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	19.03	9.97	2.17	0.18	0.72	0.91	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.72	4.82	0.48	0.16	0.48	0.32	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	17.12	9.00	1.78	1.89	1.45	0.44	0.89	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.32	0.99	2.97	4.29	1.32	0.44	0.99	0.11
epididymis, adult	10197-103E8	19.26	11.09	2.30	0.00	0.42	0.42	0.42	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.97	8.34	4.79	0.35	3.55	0.89	0.53	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.86	7.47	1.97	1.18	1.18	0.00	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	8.65	0.52	3.15	2.10	0.39	0.00	2.62	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.02	0.30	5.81	3.15	0.98	0.30	5.81	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	10.19	0.56	2.80	1.46	0.34	0.22	1.57	0.00
esophagus, adult, pool1	10015-101C6	20.17	11.89	2.97	0.42	0.32	0.53	0.11	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	31.18	18.79	4.13	0.25	4.88	1.13	0.50	0.50
eye - muscle inferior rectus, donor1	10272-104E2	24.15	9.66	2.41	0.00	0.00	2.41	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	16.83	14.73	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	2.98	2.98	0.00	0.00	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	26.37	9.17	0.00	0.00	1.15	0.00	2.29	1.15
eye - vitreous humor, donor1	10268-104D7	10.20	2.91	0.00	2.91	1.46	1.46	2.91	1.46
eye, fetal, donor1	10054-101G9	15.25	7.63	6.36	0.51	0.00	0.51	0.00	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	11.03	7.57	1.41	0.90	0.90	0.64	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	18.99	5.94	1.90	1.66	1.19	0.47	1.19	0.71
frontal lobe, adult, pool1	10040-101F4	17.92	4.88	4.03	0.38	1.03	0.66	1.22	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.71	8.71	2.40	1.80	1.50	1.20	3.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	8.60	2.83	3.66	1.92	1.28	0.09	0.09	0.09
gall bladder, adult	10198-103E9	24.38	12.55	3.38	0.48	0.97	2.41	1.21	0.24
gamma delta positive T cells, donor1	11937-126A2	46.17	13.42	3.22	3.22	0.54	0.54	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	34.73	20.54	4.48	1.12	0.37	1.49	0.75	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.52	11.83	2.75	1.06	0.63	0.63	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.37	6.96	1.35	1.74	0.39	0.00	1.55	0.19
gastric cancer cell line:AZ521	10549-107H9	33.61	16.56	5.90	2.79	1.97	0.82	3.44	0.16
gastric cancer cell line:GSS	10560-108A2	10.07	2.75	0.92	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.78	12.57	4.34	2.06	2.97	2.97	1.37	2.28
giant cell carcinoma cell line:LU65	10487-107B1	4.59	2.75	0.34	0.11	0.57	0.34	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	10.50	2.94	1.26	0.42	0.84	0.70	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.69	7.23	2.00	0.25	0.50	0.50	1.75	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.07	6.54	0.42	0.32	0.63	0.53	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.16	5.20	0.98	0.14	0.14	0.00	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	10.71	3.53	2.32	0.44	1.77	0.44	0.33	0.11
glioma cell line:GI-1	10413-106B8	9.66	3.81	1.17	0.59	1.76	0.59	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	19.68	5.10	2.92	0.73	4.37	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	27.58	7.81	16.84	0.24	2.93	0.49	0.49	0.98
globus pallidus, adult, donor10258	10367-105F7	21.91	13.69	17.80	0.00	0.00	2.74	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	13.32	11.72	0.53	1.07	1.60	0.00	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	73.41	129.70	12.24	7.34	7.34	4.89	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.64	6.08	1.28	0.32	1.28	0.64	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	30.76	10.56	1.38	0.46	0.92	0.92	1.38	1.38
hIPS +CCl2, biol_rep2	14384-156C1	26.52	8.69	2.74	0.46	0.00	0.91	2.74	0.46
hIPS +CCl2, biol_rep3	14385-156C2	21.90	12.88	5.80	1.29	1.29	1.93	3.86	0.00
hIPS, biol_rep1	14380-156B6	24.43	8.62	0.00	1.44	0.00	0.00	2.87	0.00
hIPS, biol_rep2	14381-156B7	26.75	13.72	2.06	0.69	0.69	0.00	4.80	0.69
hIPS, biol_rep3	14382-156B8	11.03	7.72	4.41	0.00	1.10	0.00	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	20.11	8.33	2.30	5.75	0.00	0.86	1.44	0.00
heart - mitral valve, adult	10205-103F7	12.56	5.08	2.69	1.20	0.60	0.60	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	14.64	6.01	5.75	1.31	1.57	0.52	1.31	0.52
heart - tricuspid valve, adult	10207-103F9	27.48	16.65	2.50	0.83	2.50	0.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	18.57	5.92	5.10	0.82	1.22	0.61	1.22	0.20
heart, adult, diseased, donor1	10051-101G6	18.31	5.11	4.68	0.00	0.85	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	18.86	7.13	2.53	0.00	0.92	1.84	0.00	0.00
heart, fetal, pool1	10046-101G1	27.21	9.86	14.79	1.03	1.64	1.03	1.03	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.87	4.01	1.23	0.62	1.23	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	51.13	27.35	11.89	2.38	1.19	1.19	3.57	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	16.13	10.28	2.98	0.44	1.22	0.88	0.66	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	14.56	11.05	3.28	0.24	0.61	1.70	1.34	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	15.87	12.83	4.24	0.40	1.11	1.52	2.22	0.20
hepatoma cell line:Li-7	10484-107A7	7.56	3.45	1.11	0.33	0.44	0.44	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.46	12.76	2.51	2.31	1.41	1.91	2.71	1.31
hippocampus - adult, donor10196	10169-103B7	15.14	2.84	5.68	0.00	0.95	0.95	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	23.06	7.14	7.35	0.41	3.27	1.43	1.22	1.63
hippocampus, adult, donor10258	10374-105G5	18.92	4.98	3.98	1.00	0.50	0.00	0.50	2.49
hippocampus, newborn, donor10223	10363-105F3	18.33	9.87	3.52	1.41	0.70	1.06	1.06	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	27.47	14.65	3.05	0.00	2.44	2.44	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.58	7.27	3.14	0.39	1.96	3.34	3.73	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.66	13.96	1.52	1.02	2.54	2.79	2.79	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	42.29	24.25	3.38	0.56	2.26	3.95	1.13	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	49.58	28.40	6.71	0.26	5.16	3.61	0.52	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.72	23.92	3.42	0.00	3.42	3.04	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	41.17	30.95	7.88	1.75	4.67	3.21	2.92	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	42.65	24.13	8.40	0.65	4.52	1.29	1.94	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.20	21.27	4.17	0.83	1.67	0.83	1.25	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.15	17.05	6.63	0.71	2.13	1.18	0.71	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	25.23	28.93	6.59	0.80	4.98	2.73	1.29	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.14	16.83	4.71	0.00	0.67	2.02	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.66	7.67	2.35	1.10	2.82	1.72	2.97	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.06	9.33	1.47	1.47	3.44	1.97	4.91	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	15.71	6.11	3.49	0.00	0.00	2.62	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	61.28	28.83	8.21	0.57	6.49	3.25	0.76	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	63.23	33.58	5.23	1.31	6.54	2.18	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	60.97	30.49	4.00	0.00	8.00	5.00	0.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.01	17.52	7.35	1.13	3.39	0.57	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.01	20.46	10.00	0.45	2.73	1.36	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.19	17.85	8.14	0.63	3.13	1.57	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.56	17.80	2.78	0.33	4.08	1.14	0.65	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.06	17.71	2.32	0.00	2.32	2.03	1.16	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	31.98	24.51	1.79	0.00	3.29	2.99	0.60	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	25.86	10.16	2.96	0.92	2.77	2.59	4.06	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.67	13.12	2.57	0.29	2.85	2.57	2.00	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	28.58	13.88	5.31	1.22	2.86	4.08	2.86	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	46.12	32.04	4.22	1.06	6.34	1.06	0.70	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.66	27.87	2.53	0.63	4.43	1.27	0.32	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.95	28.14	3.03	0.30	2.12	1.82	0.91	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	31.54	20.17	5.69	0.00	2.59	1.55	0.52	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	26.57	19.92	9.30	0.66	2.66	0.66	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.78	21.55	5.13	1.28	2.05	1.54	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.08	15.85	4.60	0.26	3.07	1.28	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	18.93	2.27	0.00	3.03	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.79	19.49	1.68	1.34	1.34	2.02	0.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.98	14.25	3.62	1.45	3.86	2.66	5.07	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.07	13.82	1.78	1.34	0.89	1.78	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	33.17	16.10	3.41	0.49	3.90	3.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.34	24.14	7.03	0.92	5.20	1.53	0.61	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	32.53	6.51	3.25	3.25	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	43.35	19.19	7.61	0.99	4.30	1.99	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	33.93	26.82	5.47	2.19	3.83	1.64	2.19	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.23	22.07	8.69	1.09	2.53	2.53	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.76	20.28	9.96	1.78	3.91	1.42	2.14	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	19.09	1.19	0.00	2.39	2.39	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	22.21	18.96	4.06	0.27	3.93	2.17	1.22	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	17.24	12.93	3.23	0.27	2.69	2.42	1.62	1.62
immature langerhans cells, donor1	11904-125F5	15.50	9.93	0.24	5.81	0.00	0.48	1.94	0.48
immature langerhans cells, donor2	11905-125F6	13.47	23.76	0.79	3.96	0.00	0.79	0.79	1.58
insula, adult, pool1	10039-101F3	22.14	8.99	5.77	0.19	1.61	1.61	1.99	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	10.73	10.73	1.30	0.65	1.63	0.65	0.00	0.33
kidney, adult, pool1	10017-101C8	12.32	7.91	2.30	0.30	0.50	1.40	0.90	0.10
kidney, fetal, pool1	10045-101F9	28.37	12.80	9.05	1.34	1.98	1.84	1.70	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	14.20	6.39	5.96	0.99	1.42	0.85	1.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.22	3.59	1.52	0.00	0.28	0.28	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.81	0.55	4.59	6.97	0.37	0.18	1.28	0.00
left atrium, adult, donor1	10079-102A7	11.44	4.90	3.81	0.54	1.09	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	11.12	3.03	3.54	0.00	0.51	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.89	11.77	2.46	0.27	4.10	1.09	0.27	1.09
leiomyoma cell line:10964C	10569-108B2	2.51	1.08	0.00	0.00	0.36	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	4.35	0.54	0.54	0.00	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	3.16	1.21	0.73	0.00	0.24	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	5.23	5.23	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.32	10.27	1.18	1.65	0.83	0.47	1.77	0.59
liposarcoma cell line:KMLS-1	10782-110G8	6.56	1.72	1.09	0.00	0.62	0.47	0.00	0.47
liposarcoma cell line:SW 872	10726-110A6	11.21	7.31	1.22	0.24	1.46	0.61	0.37	0.61
liver, adult, pool1	10018-101C9	10.05	6.64	0.32	0.16	0.65	1.62	0.00	0.00
liver, fetal, pool1	10086-102B5	12.23	0.94	0.00	0.00	1.88	0.94	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	15.75	4.37	5.98	0.15	1.75	0.58	0.87	2.77
locus coeruleus, adult, donor10252	10165-103B3	25.28	7.94	6.27	0.18	1.48	1.29	0.74	1.66
locus coeruleus, adult, donor10258	10375-105G6	9.59	5.92	3.67	0.28	1.13	2.26	0.56	1.41
locus coeruleus, newborn, donor10223	10362-105F2	13.46	9.25	1.68	0.42	0.42	2.94	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	12.59	3.32	0.83	0.14	0.83	0.14	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	14.48	12.41	0.69	1.38	0.69	3.45	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.84	6.85	9.23	5.40	1.85	0.40	1.45	0.00
lung, adult, pool1	10019-101D1	18.90	9.69	2.48	0.83	0.95	0.71	0.24	0.24
lung, fetal, donor1	10068-101I5	42.53	8.56	16.84	3.14	3.14	2.00	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	29.33	11.00	4.58	1.37	0.92	0.92	0.46	0.00
lymph node, adult, donor1	10077-102A5	33.61	15.62	1.42	4.26	1.42	0.95	1.89	1.89
lymphangiectasia cell line:DS-1	10727-110A7	16.88	8.33	0.88	3.07	0.66	1.32	1.75	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.30	18.87	3.02	6.04	0.60	0.15	0.75	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	13.59	11.89	0.85	13.59	0.00	0.00	5.95	0.85
mature adipocyte, donor1	12231-129F8	12.88	6.66	5.33	0.00	1.33	0.89	0.00	0.44
mature adipocyte, donor2	12232-129F9	13.28	6.23	2.49	1.04	0.21	0.83	0.21	0.00
mature adipocyte, donor3	12233-129G1	13.28	5.45	2.84	0.95	0.71	0.71	0.00	0.00
mature adipocyte, donor4	12234-129G2	16.06	5.53	4.21	0.26	0.00	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	43.84	40.03	12.39	3.57	0.95	3.81	3.10	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	2.26	2.26	0.00	0.00	2.26	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	16.37	7.91	8.64	0.37	0.55	1.10	0.92	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	9.21	6.67	2.22	0.00	0.00	0.64	0.64	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	14.93	6.40	4.26	0.00	1.28	2.13	2.56	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	12.15	6.58	5.91	0.00	1.86	1.69	1.52	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	16.77	10.19	10.61	0.00	0.85	1.06	2.76	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.56	11.13	2.87	0.36	1.79	1.44	2.51	1.08
medulla oblongata - adult, donor10196	10174-103C3	13.63	5.19	3.24	1.30	0.65	1.95	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	16.87	8.05	7.43	0.15	1.55	0.93	0.46	1.24
medulla oblongata, adult, pool1	10038-101F2	24.98	7.43	7.67	0.73	1.71	1.31	0.57	1.06
medulla oblongata, newborn, donor10223	10361-105F1	18.75	7.29	3.82	0.00	2.08	1.04	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	48.49	27.90	20.37	1.55	2.21	1.77	3.32	1.33
medulloblastoma cell line:ONS-76	10759-110E3	17.85	6.60	1.35	2.32	1.83	0.24	1.35	0.12
melanoma cell line:COLO 679	10514-107E1	10.06	6.18	1.29	0.29	0.57	0.29	0.57	0.00
melanoma cell line:G-361	10465-106H6	6.52	7.33	2.17	0.00	0.54	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	9.05	3.44	0.36	0.00	0.18	1.09	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	21.15	26.43	8.81	1.76	1.76	0.00	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	35.77	41.99	20.48	2.07	4.41	3.11	3.63	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	5.98	2.61	0.46	0.15	1.53	1.23	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	2.91	1.82	0.00	0.00	0.36	0.18	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.48	0.83	0.00	0.00	0.41	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	5.48	2.25	0.98	0.00	0.14	0.00	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3.27	2.50	0.96	0.00	0.19	0.39	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.25	4.86	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2.92	1.72	0.69	0.00	0.86	0.17	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.98	3.22	0.00	0.00	1.04	0.58	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.23	3.58	0.40	0.13	0.27	0.13	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.00	2.03	0.54	0.68	0.68	0.54	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	6.12	2.70	0.28	0.00	0.71	0.28	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.92	2.63	0.33	0.00	0.00	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.20	3.60	0.00	0.00	0.97	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	4.19	2.79	0.70	0.00	0.35	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	4.08	1.84	0.61	0.00	0.61	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.63	3.24	1.44	0.00	0.00	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.93	2.69	0.52	0.00	0.21	0.31	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.02	1.37	0.68	0.46	0.91	0.23	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	1.68	0.84	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4.93	2.84	0.45	0.00	0.30	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	5.95	2.98	0.70	0.00	0.96	0.26	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.05	4.79	0.37	0.00	0.00	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.58	3.15	2.00	0.00	0.86	0.29	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.26	5.89	3.37	0.00	0.00	0.42	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.02	4.11	0.00	0.46	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	3.33	3.33	0.77	0.26	0.26	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	3.93	6.28	0.26	0.26	0.26	0.52	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	3.08	5.55	0.31	0.00	0.62	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.18	4.47	0.24	0.00	0.24	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.42	3.05	0.68	0.00	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.14	2.36	0.39	0.00	0.39	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	3.24	1.85	0.46	0.00	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	4.04	3.75	1.44	0.00	0.00	0.58	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	2.90	4.24	0.22	0.00	0.22	0.45	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.05	4.81	0.72	0.00	0.24	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	2.20	5.87	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.71	5.03	0.67	0.00	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.09	3.68	1.23	0.41	0.41	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.01	4.73	0.00	0.00	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	5.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	1.95	4.87	1.30	0.00	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	0.00	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.20	3.20	0.00	0.00	2.13	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	4.09	0.00	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.28	3.11	0.00	0.00	0.39	0.78	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	8.39	0.00	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	1.99	1.99	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	4.15	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1.22	3.66	0.00	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	1.90	0.00	0.00	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.52	3.79	0.34	0.00	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	4.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.44	3.26	0.00	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	2.38	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	1.77	0.59	0.00	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1.87	3.43	0.62	0.00	0.31	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	6.68	0.00	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1.18	4.73	2.37	0.00	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	7.70	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	5.51	6.88	0.69	0.00	0.00	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	2.97	1.48	0.00	0.49	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	3.36	2.24	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	4.45	0.64	0.00	1.27	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.43	4.03	1.21	0.00	0.81	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	6.54	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	5.07	2.53	0.00	1.27	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.07	4.86	1.21	0.00	0.00	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	6.59	1.65	1.65	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.76	3.17	0.40	0.00	0.20	0.79	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.89	4.54	0.32	0.00	0.32	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	5.09	7.13	0.00	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	6.19	0.77	0.00	3.09	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	25.04	5.91	0.94	0.24	1.89	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	13.21	9.27	0.23	0.23	1.85	0.70	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.82	5.34	0.72	0.41	0.72	0.82	0.00	0.62
mesothelioma cell line:Mero-25	10850-111F4	4.99	5.22	1.82	1.36	0.23	0.45	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	10.51	11.49	1.71	0.98	1.71	0.00	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	5.76	1.77	0.89	0.00	0.00	0.44	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	7.10	6.57	2.37	0.79	1.58	0.26	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	12.09	9.02	1.36	0.17	1.02	0.85	0.85	1.70
mesothelioma cell line:Mero-84	10855-111F9	5.06	1.77	0.76	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.25	5.38	0.83	0.00	0.62	0.21	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	7.45	2.48	1.33	0.33	0.66	0.17	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	9.05	4.16	1.27	0.36	0.00	0.54	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	9.57	7.17	1.02	0.68	0.85	0.68	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	5.09	3.56	1.78	0.25	0.00	0.51	0.51	0.00
mesothelioma cell line:No36	10857-111G2	2.28	3.59	0.98	0.33	0.00	1.30	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	4.34	3.25	1.35	0.27	0.54	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	37.42	6.72	1.34	5.57	0.58	0.38	0.58	0.58
migratory langerhans cells, donor2	11902-125F3	32.60	7.69	1.10	3.54	0.24	1.34	0.85	0.12
migratory langerhans cells, donor3	11903-125F4	31.95	7.36	1.26	3.95	0.18	0.72	0.90	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	2.61	1.96	0.65	0.00	0.33	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.99	4.87	1.91	0.42	0.64	0.21	1.06	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	17.28	7.83	0.92	1.15	2.30	0.00	1.38	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.03	4.76	2.47	4.95	1.14	0.38	1.33	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	25.32	16.45	1.29	0.74	3.33	1.29	0.92	0.55
myeloma cell line:PCM6	10474-106I6	16.80	6.72	11.27	8.70	0.40	0.20	3.16	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	3.55	0.51	0.51	0.51	1.01	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.22	11.18	2.16	0.20	1.37	1.18	0.98	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.79	2.45	0.22	0.00	0.11	0.33	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.12	2.79	0.29	0.00	0.22	0.51	0.07	0.07
nasal epithelial cells, donor2	12227-129F4	36.98	17.66	2.76	2.21	2.76	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	13.80	7.13	20.25	3.45	3.45	0.23	2.07	0.23
neuroblastoma cell line:NB-1	10539-107G8	16.28	6.17	6.55	1.87	1.68	0.37	0.94	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	18.14	14.97	2.95	0.84	0.42	0.21	1.48	0.42
neuroblastoma cell line:NH-12	10555-107I6	20.31	10.25	5.03	0.37	2.24	0.56	0.19	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.38	11.15	3.08	0.95	1.90	0.24	1.19	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	21.70	21.22	4.28	0.79	2.53	2.22	0.95	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	19.92	10.67	1.61	0.20	2.21	1.41	1.61	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.80	34.33	1.27	1.91	1.91	0.64	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	7.45	5.59	1.33	0.00	0.53	0.80	0.53	0.27
neutrophil PMN, donor1	12133-128D9	59.50	14.87	29.75	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.64	21.65	11.33	5.24	2.54	0.68	0.51	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	6.40	8.81	0.80	0.00	0.80	1.60	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.41	5.77	3.21	0.00	0.32	0.32	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	6.31	1.84	1.58	0.26	0.26	0.53	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	20.90	6.94	5.72	0.66	1.12	1.69	1.22	0.66
occipital cortex - adult, donor10196	10172-103C1	16.48	6.18	2.06	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	28.18	8.59	9.39	0.00	1.61	1.34	2.15	4.56
occipital cortex, newborn, donor10223	10355-105E4	25.48	10.55	2.55	1.46	0.36	0.73	3.28	0.73
occipital lobe, adult, donor1	10076-102A4	21.52	4.46	3.94	1.05	0.52	1.57	1.05	0.79
occipital lobe, fetal, donor1	10073-102A1	43.77	14.16	7.72	1.29	3.86	1.72	6.01	1.72
occipital pole, adult, pool1	10036-101E9	19.47	7.65	4.42	0.32	1.42	0.71	1.26	1.02
olfactory region, adult	10195-103E6	23.50	6.50	6.30	0.00	1.34	0.96	1.15	0.76
optic nerve, donor1	10277-104E7	32.02	4.00	6.00	2.00	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.57	9.80	0.91	0.11	0.57	1.03	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	9.34	3.85	2.75	0.82	0.69	0.14	0.55	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.14	5.08	1.35	0.51	1.69	0.51	1.02	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.55	5.54	1.73	2.54	0.81	0.23	0.46	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	11.76	4.70	1.18	0.29	1.76	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	4.67	0.00	6.54	3.74	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	12.30	11.24	0.85	0.21	0.42	0.85	0.21	0.85
ovary, adult, pool1	10020-101D2	14.59	10.74	5.85	1.14	0.52	4.11	0.35	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.47	4.03	1.10	0.73	1.28	0.92	0.73	0.73
pancreas, adult, donor1	10049-101G4	15.05	14.11	2.82	1.88	0.00	2.82	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.88	8.39	3.07	0.84	0.56	0.84	2.24	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	7.33	3.75	1.53	0.68	0.51	0.34	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.74	5.63	2.98	0.99	0.99	0.66	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	18.95	5.86	6.13	0.27	1.01	0.64	0.82	0.73
parietal cortex, adult, donor10258	10373-105G4	37.43	19.08	7.34	0.00	1.47	0.73	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	18.81	4.70	3.76	0.00	0.94	0.00	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	19.38	6.84	4.56	0.00	0.86	0.86	0.57	2.85
parietal lobe, adult, pool1	10034-101E7	18.51	5.64	5.64	0.35	1.32	0.79	0.53	0.79
parietal lobe, fetal, donor1	10072-101I9	57.22	14.55	10.67	0.97	6.79	4.85	3.88	5.82
parietal lobe, newborn, donor10223	10356-105E5	20.94	6.36	1.50	0.75	0.37	0.00	2.99	0.37
parotid gland, adult	10199-103F1	6.17	7.40	1.23	0.62	1.85	0.62	0.62	0.00
penis, adult	10200-103F2	15.58	5.91	4.30	0.00	0.00	0.54	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.59	4.46	1.49	0.00	0.00	0.19	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.49	4.23	5.25	1.31	1.31	0.44	0.87	0.00
pineal gland - adult, donor10196	10179-103C8	20.00	11.61	5.81	0.00	1.94	3.87	2.58	3.23
pineal gland, adult, donor10252	10160-103A7	36.12	22.50	13.62	0.59	0.59	3.55	5.33	4.15
pineal gland, adult, donor10258	10377-105G8	15.68	15.05	6.27	0.00	1.25	1.88	2.51	1.25
pituitary gland - adult, donor10196	10180-103C9	15.18	11.13	4.05	0.00	1.01	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	29.19	16.68	8.86	0.52	0.52	2.61	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	28.09	12.77	2.55	0.85	0.00	1.70	0.85	0.00
placenta, adult, pool1	10021-101D3	21.50	9.57	3.98	0.22	0.32	0.43	0.86	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	20.00	7.02	2.38	7.28	0.26	0.13	0.93	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	7.63	2.33	2.33	0.00	0.16	0.31	0.31	0.00
pons, adult, pool1	10033-101E6	10.84	4.82	5.68	0.43	0.77	0.77	1.12	0.26
postcentral gyrus, adult, pool1	10032-101E5	19.96	6.71	5.14	0.35	1.13	0.52	0.70	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	129.67	14.64	10.46	2.09	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	5.51	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	35.21	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.91	7.72	0.58	0.73	0.44	0.15	0.44	0.00
prostate cancer cell line:PC-3	10439-106E7	17.61	8.53	2.36	0.36	0.91	1.45	0.36	0.00
prostate, adult, pool1	10022-101D4	15.51	9.61	5.17	0.45	0.82	0.82	0.27	0.18
putamen, adult, donor10196	10176-103C5	20.30	5.19	7.79	0.24	0.71	0.71	1.18	0.94
putamen, adult, donor10252	10152-102I8	11.76	11.76	5.88	0.00	1.96	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	6.56	0.00	0.00	2.19	0.00	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	13.05	8.46	3.38	0.24	0.97	1.69	1.21	0.97
putamen, newborn, donor10223	10365-105F5	13.49	5.25	5.25	0.00	0.75	0.75	4.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	23.57	6.11	7.56	4.36	1.45	0.58	0.58	0.58
rectum, fetal, donor1	10067-101I4	50.08	5.56	9.74	0.00	6.95	1.39	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.96	5.51	1.06	1.27	0.21	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	11.18	3.31	2.90	0.41	0.00	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	26.64	9.74	8.25	0.80	1.49	1.89	0.89	1.19
retinoblastoma cell line:Y79	10475-106I7	28.58	17.41	4.94	0.00	1.82	1.56	1.56	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	25.82	15.74	1.84	0.25	2.09	0.74	0.25	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.59	7.31	3.66	1.12	2.81	0.84	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	10.61	7.58	3.79	0.00	0.76	0.00	0.00	2.27
salivary acinar cells, donor1	11771-123I7	8.74	5.18	1.29	0.00	0.32	0.49	0.32	0.00
salivary acinar cells, donor2	11772-123I8	10.60	4.54	1.51	0.14	0.55	1.10	0.00	0.14
salivary acinar cells, donor3	11773-123I9	22.51	11.25	1.99	0.00	0.00	1.32	0.00	1.32
salivary gland, adult, pool1	10093-102C3	28.03	14.30	2.86	1.72	0.00	2.29	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	6.41	3.79	0.42	0.25	0.42	0.84	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	5.52	3.76	0.82	0.12	0.47	0.00	0.12	0.00
seminal vesicle, adult	10201-103F3	23.28	12.17	7.94	2.12	0.53	1.06	3.17	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.99	7.77	1.46	0.49	0.24	0.49	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.01	1.76	0.25	0.25	0.75	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	2.01	0.00	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.21	4.57	4.84	0.81	0.67	0.13	1.07	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	10.83	7.07	1.33	0.00	0.33	0.77	0.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.64	3.61	1.16	0.52	0.65	0.52	0.90	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	14.19	0.71	0.71	1.42	0.00	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	23.51	9.83	3.12	0.60	1.20	1.68	0.00	0.24
skeletal muscle, fetal, donor1	10066-101I3	11.06	9.05	4.02	0.00	1.01	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	15.78	14.52	3.16	0.63	1.89	0.63	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.68	8.34	3.00	0.67	1.00	2.33	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.88	21.75	5.99	2.52	3.47	1.89	1.26	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	35.85	42.21	6.36	1.93	0.77	2.89	5.98	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	24.89	16.32	6.59	0.66	0.49	0.66	1.15	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	26.22	14.15	9.97	0.48	0.32	0.97	0.32	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	31.60	13.95	10.68	6.32	1.31	0.87	3.92	0.00
small intestine, adult, pool1	10024-101D6	27.47	10.99	4.90	0.84	0.36	1.79	0.96	0.24
small intestine, fetal, donor1	10064-101I1	11.79	9.58	5.90	0.74	0.98	1.23	1.97	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	11.80	3.08	0.00	0.51	1.54	1.03	1.54
smooth muscle, adult, pool1	10048-101G3	20.93	2.33	4.39	0.00	0.78	1.03	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	12.60	4.29	3.22	0.00	1.07	0.27	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	17.66	4.36	3.90	0.23	2.29	1.61	1.15	0.69
spinal cord, adult, donor10252	10159-103A6	22.47	7.49	6.70	0.00	3.15	2.37	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	15.91	2.77	3.46	0.00	1.38	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	34.15	9.15	7.32	0.61	3.05	1.22	3.05	2.44
spinal cord, newborn, donor10223	10359-105E8	20.66	9.64	5.05	0.00	2.30	1.38	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.62	4.18	1.94	0.30	1.49	0.45	0.15	0.00
spleen, adult, pool1	10025-101D7	25.33	13.44	2.09	2.20	0.66	0.99	0.44	0.44
spleen, fetal, pool1	10044-101F8	34.72	12.95	4.21	2.30	1.11	1.75	0.48	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	18.43	6.31	1.45	2.28	0.41	1.04	0.52	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	10.82	4.94	1.90	0.38	0.38	0.57	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.41	6.64	9.78	0.35	1.75	2.10	1.05	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.47	3.13	1.17	1.95	0.78	0.78	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	14.29	5.40	2.70	1.46	1.01	1.01	2.14	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.86	5.08	0.42	0.00	0.00	0.85	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.38	11.42	0.42	0.85	0.00	0.42	0.85	0.00
stomach, fetal, donor1	10062-101H8	29.90	14.95	5.34	2.14	3.20	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	16.52	13.67	4.56	0.57	0.00	0.57	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	108.55	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	24.09	7.06	14.95	0.21	1.87	1.25	0.62	1.04
substantia nigra, adult, donor10258	10371-105G2	17.07	5.17	2.07	0.00	2.07	0.00	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	18.37	11.31	3.53	0.00	0.00	1.41	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	21.78	16.28	3.21	0.23	0.92	1.38	0.92	2.06
temporal lobe, adult, pool1	10031-101E4	19.75	6.70	6.19	0.42	1.70	1.27	1.02	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.12	20.66	14.96	0.00	3.56	0.00	7.12	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	58.90	17.14	5.71	1.76	2.64	0.88	3.08	0.44
tenocyte, donor1	11763-123H8	3.84	3.49	1.75	0.00	0.70	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	2.67	4.20	0.76	0.00	0.00	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	4.82	3.71	0.74	0.00	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	48.61	17.00	7.65	1.87	2.21	2.21	3.74	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	19.42	14.34	3.08	0.00	1.39	3.08	1.08	0.77
teratocarcinoma cell line:PA-1	10807-111A6	21.23	11.16	3.10	0.62	4.34	1.24	1.08	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	16.88	8.76	3.17	1.27	0.76	1.14	1.78	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	25.72	7.94	7.56	1.13	0.00	0.00	2.65	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.25	3.05	4.69	2.94	0.55	0.98	1.20	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.33	4.56	4.23	0.65	0.00	0.98	1.95	0.00
testis, adult, pool1	10026-101D8	18.25	13.10	3.11	0.64	0.86	2.68	1.07	0.43
testis, adult, pool2	10096-102C6	21.65	14.89	2.71	0.45	0.45	1.35	6.77	0.45
thalamus - adult, donor10196	10168-103B6	14.35	4.42	7.73	2.21	0.00	1.10	1.10	1.10
thalamus, adult, donor10252	10154-103A1	23.75	7.81	14.69	0.16	2.19	1.09	0.94	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	7.70	3.08	0.00	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.52	6.75	2.14	0.66	0.33	1.65	1.15	1.48
thalamus, newborn, donor10223	10366-105F6	6.90	6.90	4.03	0.58	2.30	1.73	2.88	1.73
throat, adult	10209-103G2	19.97	7.24	2.25	1.00	1.00	1.00	0.75	1.00
throat, fetal, donor1	10061-101H7	21.63	8.53	4.88	0.30	1.52	0.30	0.91	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	34.98	31.80	3.38	1.59	1.19	1.99	0.79	0.99
thymus, adult, pool1	10027-101D9	75.36	33.11	9.44	3.28	1.89	2.39	2.39	0.50
thymus, fetal, pool1	10043-101F7	73.56	22.03	11.64	3.53	2.81	1.45	1.45	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	12.76	3.86	0.66	0.80	0.53	0.13	0.27	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	11.87	6.43	1.96	0.98	0.98	0.14	1.54	0.14
thyroid, adult, pool1	10028-101E1	18.48	11.48	5.23	0.93	0.56	1.59	0.37	0.37
thyroid, fetal, donor1	10060-101H6	27.42	12.39	5.27	1.85	1.85	1.32	3.43	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	21.56	0.00	0.00	0.00	6.16	0.00	9.24
tongue, adult	10203-103F5	10.93	9.77	2.79	0.47	0.70	0.70	0.23	0.47
tongue, fetal, donor1	10059-101H5	13.40	9.85	3.15	0.00	0.79	0.39	0.39	0.79
tonsil, adult, pool1	10047-101G2	34.26	16.73	5.61	5.11	0.70	1.80	1.10	0.80
trachea, adult, pool1	10029-101E2	13.50	7.93	4.66	0.41	0.57	0.49	0.08	0.25
trachea, fetal, donor1	10058-101H4	17.70	11.16	3.08	0.38	0.38	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.44	6.02	2.48	0.35	1.06	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	18.34	13.88	3.04	1.01	1.11	0.91	0.81	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.16	8.93	1.72	1.10	0.47	1.41	0.94	0.16
tridermal teratoma cell line:HGRT	10694-109G1	9.51	9.51	0.00	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.81	1.95	1.19	0.51	0.25	0.17	0.08	0.17
umbilical cord, fetal, donor1	10057-101H3	12.52	8.35	6.26	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	32.93	10.92	5.80	0.51	2.22	1.19	0.51	0.34
uterus, fetal, donor1	10055-101H1	28.16	9.73	5.63	0.51	2.56	1.02	0.51	1.02
vagina, adult	10204-103F6	24.56	7.75	2.58	0.00	0.65	0.65	0.00	1.29
vein, adult	10191-103E2	26.08	10.08	5.04	1.53	0.22	0.44	1.53	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	18.69	5.87	0.27	2.67	0.80	0.80	0.00	0.53